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Alginates are natural polymers useful in the design of pharmaceutical dosage forms. 
Alginates are available in many different grades and these grades vary in their 
physicochemical properties, namely particle size, viscosity and mannuronic/guluronic 
acid ratio. The impact of these variables on drug release and hydration behavior of 
sodium alginate matrix tablets is not well characterized, particularly in simulated 
gastrointestinal pH conditions. At gastric pH, the integrity of alginate matrix tablets 
was compromised by crack development, potentially limiting the use of alginate 
matrices for oral drug delivery. Recent interest in the use of natural polymers in the 
pharmaceutical industry provided further impetus for this study. 
 
The impact of alginate physicochemical properties on drug release and matrix 
hydration behavior was evaluated using a variety of alginate grades. The median 
particle size of alginate affected the extent of burst release, indicating its role in 
alginic acid barrier development. Alginate with higher viscosity showed lower rate of 
polymer hydration, resulting in enhanced burst and drug release at pH 1.2. However, 
higher viscosity alginate formed gel barrier with reduced erodibility at pH 6.8, 
contributing to slower drug release. The MG ratio of alginate appeared to influence 
the integrity of the alginic acid barrier. High-G alginate matrices showed greater 
propensity to laminate at acidic pH compared to high-M alginate matrices. These 
findings suggest that alginate physicochemical properties can be employed to modify 




Alginate matrices demonstrated pH-dependent hydration, swelling and erosion 
behavior, resulting in pH-dependent drug release mechanisms. Anisotropy was 
observed during hydration of alginate matrices and was implicated in crack 
development. Cross-linking and micro-environmental pH modulation were proposed 
to reduce the propensity of alginate matrices to crack. Improved mechanical strength 
and reduced barrier permeability of calcium alginate gel provided the rationale for 
cross-linking alginate matrices. Matrices pre-coated with calcium alginate could 
sustain drug release at pH 1.2 followed by pH 6.8 for over 12 h. The presence of 
cross-linked barrier impeded matrix lamination and preserved matrix structure, 
contributing to at least three-fold reduction in drug release at pH 1.2. Zero order 
release as well as delayed burst release was produced by varying the cross-linking  
conditions used. Lamination was associated with the conversion of sodium alginate to 
alginic acid. Hence, inclusion of pH-modifiers was employed to raise the micro-
environmental pH within matrices undergoing dissolution at gastric pH. The changes 
in micro-environmental pH of hydrating alginate matrices were visualized with the 
aid of a pH-indicator and subsequently quantified using image analysis. Transient 
elevation in micro-environmental pH impeded alginate protonation and minimized or 
prevented matrix lamination, contributing to preservation of drug diffusion barrier. 
Significant reduction in the rate of drug release at pH 1.2 was achieved in the 
presence of such additives. The action of pH-modifiers was synergistically enhanced 
in the presence of an air barrier formed by effervescing sodium bicarbonate, reducing 
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A. Alginates for drug delivery 
A1. Sources of alginate 
Commercial alginates are extracted primarily from marine brown algae 
(Phaeophyceae), particularly Laminaria hyperborea, Ascophyllum nodosum and 
Macrocystis pyrifera (Gombotz and Wee, 1998; Gacesa, 1988). As structural 
components, the intercellular alginate gel matrix confers mechanical strength and 
flexibility to the marine plant (Draget, 2000). Alginates are also isolated from the 
capsules of bacteria such as Azotobacter vinelandii and several Pseudomonas species 
(Shilpa et al., 2003; Gacesa, 1988). Essentially, the extraction of alginate from algal 
material involves pre-treatment with mineral acid to convert the alginate gel to 
insoluble alginic acid, followed by neutralization with sodium hydroxide or sodium 
carbonate to form the soluble sodium alginate. The latter is then collected and 
precipitated directly by alcohol, calcium chloride or mineral acid, converted to the 
sodium form if needed, dried and finally milled (Draget, 2000).  
 
A2. Structure of alginate 
Alginates are linear unbranched polysaccharides containing varying proportions of β-
D-mannuronic acid (M) and its C-5 epimer, α-L-guluronic acid (G) (Fig. 1). The M 
and G monomers are 1Æ4 linked by glycosidic bonds, forming homopolymeric M- or 
G-blocks, which are interspersed with heteropolymeric MG-blocks. The M and G 
residues adopt opposite conformations of the pyranose rings (4C1 and 1C4, 
respectively) such that the bulky carboxyl group is in the energetically favored 
equatorial position (Gacesa, 1988), resulting in different shapes of the M- and G- 
blocks (Usov, 1999). The M-blocks are flat and ribbon-like due to di-equatorial 
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linkage, while the G-blocks are corrugated (buckled) due to di-axial bonding (Shilpa 
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Fig. 1. Structural characteristics of sodium alginate: (A) alginate monomers, (B) chain 




The segmental nature of alginate confers different backbone chain flexibility to the 
polymer in solution. This is due to the difference in hindrance to rotation around the 
glycosidic linkage in the different segments (Smidsrød et al., 1973). Light-scattering 
and viscosity measurements indicated that the relative stiffness of the three types of 
building blocks in alginate increased in the order: MG-blocks < M-blocks < G-blocks 
(Smidsrød et al., 1973). The α (1–4) linkage of the guluronic acid residues causes 
greater steric hindrance from the carboxyl groups and thus high-M content alginate 
chains are more flexible in solution than high-G content alginate chains (Whittington, 
1971). The greater rigidity of G-blocks relative to M-blocks had also been verified by 
more recent studies (Lee et al., 2002, Braccini et al., 1999).  
 
Alginates are polydisperse and are available in various viscosity grades. The 
composition, sequence of polymer blocks and molecular weight of alginate depend on 
the source of marine algae, tissue from which alginates are extracted, and also the 
season of crop harvesting. Variability in these factors affects the physical properties 
of the alginate gel formed.  
 
A3. Functional properties of alginate 
A3.1 pH-dependent hydration and solubility 
The presence of pendent acidic groups that can accept or release protons in response 
to pH changes makes alginate pH-sensitive. The pKa of M and G monomers are 3.38 
and 3.65, respectively (Haug, 1964). Depending on the type of alginate and the salts 
present in the mixture, alginic acid may have pKa values ranging from 3.4 to 4.4 
(McNeely and Pettitt, 1973). Approximately 50 % of the carboxyl groups will be 
protonated at pH 4.0 (King, 1983). Alginic acid is water-insoluble but swellable, 
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which forms the basis of its use as a tablet disintegrant. At pH values near 5, the 
carboxyl groups are fully ionized (King, 1983) and become soluble in water. Sodium 
alginate solutions have unusually high apparent viscosity even at low concentrations, 
due to the high molecular weight and molecular rigidity of the polymer (Cottrell and 
Kovacs, 1980).  
 
At acidic pH, sodium alginate is converted to insoluble alginic acid. Even so, alginate 
matrix tablets immersed in an acidic environment did not disintegrate. On the 
contrary, an alginic acid barrier was formed. It was observed that the alginic acid 
barrier consisted of discrete polymer particles which were bound by a highly diluted 
gel (Hodsdon et al., 1995). This suggests that not all the sodium alginate was 
immediately converted to alginic acid. Polymer hydration has to precede acidification. 
Upon hydration, the particles swelled and coalesced to form a coherent structure, 
followed by gradual acidification of the whole barrier.  
 
The conversion of sodium alginate to alginic acid at acidic pH affects the behavior of 
drug delivery systems containing sodium alginate. In a matrix tablet, this would result 
in changes in the characteristics of the gel barrier and affect drug release across this 
barrier. Hodsdon et al. (1995) reported that a “viscous and soluble” gel barrier formed 
at neutral pH, whereas a “tough, rubbery rind” was observed at acidic pH, and this 
difference in gel barrier property was postulated to lead to differing drug release 
kinetics at acidic and neutral pH. The pH-dependent solubility of alginate has been 
employed in the formulation of solid dosage forms for basic, neutral or acidic drug 
molecules (Moroni and Drefko, 2002). Alginate matrix tablets were reported to crack 
or laminate at acidic pH, leading to rapid drug release (Efentakis and Buckton, 2002). 
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Crack formation would compromise the function of the diffusion barrier and this 
could limit the use of sodium alginate in oral sustained-release dosage forms. Hence, 
the potential of alginate matrix tablet as an oral drug delivery system needs further 
investigation, particularly its performance in the acidic phase. 
 
A3.2 Selective ion binding 
The most useful and unique property of alginates is their ability to react with 
polyvalent metal cations, particularly calcium ions (King, 1983). With increasing 
calcium ion content, sodium alginate solution becomes more viscous, gels, and finally 
precipitates to produce insoluble calcium alginate (King 1983). This phenomenon is 
brought about by interchain association of alginate chains to form dimers. The 
interaction between alginates and calcium ions is commonly explained using the egg-
box model (Grant et al., 1973). According to this model, calcium ion is postulated to 
fit into electronegative cavities formed between G residues, like eggs in an egg-box. 
Calcium ion preferentially interacts with the G-blocks of alginate due to structurally 
favorable chelation sites formed by the corrugated polyguluronate chains (Braccini et 
al., 1999). Preferential binding of calcium ions to polyguluronate segments was 
supported by molecular modeling studies which showed significantly lower 
interaction energies for α-(1,4)-linked polymers than for β-(1,4)-linked chains 
(Braccini et al., 1999). Further modeling studies involving a pairing procedure that 
evaluated all possible associations of ordered polyguluronate chains with calcium ions 
to form dimers concluded that the “egg-box model” adequately described the 
dimerization of polyguluronate (Braccini et al., 2001).  
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The cations act as bridges between the anionic alginate polymer chains, constituting 
junction zones which are responsible for the formation of a hydrogel network. The 
junction zone is an alignment of helices with two anhydroguluronic acid units per turn 
with the helices held together by chelate bound calcium ion (Grant et al., 1973). A 
recent study suggested that the binding of cations to alginate resulted in local charge 
reversal, transforming the polyelectrolyte into a polyampholyte. The positively 
charged segments then interacted with anionic groups on adjacent chains forming 
dimers (Siew and Williams, 2005). Dimerized polyguluronate segments can 
subsequently aggregate, forming multimeric junction zones (Braccini et al., 2001; 
Stokke et al., 1997; Rees, 1982). The initial dimerization was attributed to strong 
associations between polyguluronate chains while subsequent aggregation of these 
dimers was governed mainly by electrostatic interactions (Rees, 1982). The stronger 
initial dimerization compared to subsequent aggregation of these dimers had been 
demonstrated experimentally (Papageorgiou et al., 1994). 
 
Clearly, selective ion binding is linked to the content of G-blocks (Smidsrød, 1974). 
The selectivity of alginate towards polyvalent cations is exclusive to polyguluronate 
and is enhanced with increasing content of guluronate residues in the polymer chains 
(Smidsrød, 1974). Due to selective ion binding, cross-linking of alginates of different 
chemical composition results in gels with different properties (Skjåk-Bræk, 1992). 
The stronger affinity of guluronate for calcium ions results in the formation of stiffer 
and more brittle gels with alginates of high G content. In addition, the higher rigidity 
of the G-blocks relative to M-blocks was maintained in the presence of divalent 
cations (Smidsrød et al., 1973). On the other hand, alginates high in M content formed 
softer and more elastic gels (Penman and Sanderson, 1972). Hence, gels of different 
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properties can be fabricated using different grades of alginate to suit the intended 
application.  
 
Until recently, it was assumed that G-blocks were the only structures in the alginate 
polymer that bound divalent ions cooperatively and were, therefore, the main 
structural feature contributing to gel formation. Recent findings, however, suggest 
that MG-blocks, in addition to G-blocks, could form cross-links with calcium ions. 
This was based on evidence of gel formation from alginate consisting of strictly 
alternating monomer sequences. Hence, calcium junctions of GG–GG, MG–GG and 
MG–MG should be held responsible for gel formation (Donati et al., 2005). This 
could imply that high-G alginates, regardless of the arrangement of the guluronate 
units, can form gels in the presence of divalent cations. 
 
A4. Advantages of using alginates in pharmaceutical preparations 
In recent years, the biomedical and pharmaceutical industries have shown much 
increased interest in the use of natural polymers, particularly alginates (Shilpa et al., 
2003). The main advantages of natural polymers lie in their biocompatibility and 
biodegradability, without producing systemic toxicity on administration (Takka and 
Acarturk, 1999). In addition, natural polymers are available in abundance from 
renewable sources and are relatively inexpensive (Shilpa et al., 2003). The naturally 
occurring alginate polymer is generally regarded as safe (GRAS) since it has long 
been used in the food and beverage industries as thickening, gel-forming and 
colloidal-stabilizing agents. They are also used as binders and disintegrants in tablet 
manufacture. A myriad of new polymer and delivery systems are being developed. 
However, regulatory concerns continue to reinforce the use of materials that are 
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known to be safe for pharmaceutical use. In addition, its ability to gel under mild 
conditions makes alginate the polymer-of-choice in food, pharmaceutical and 
biotechnological applications. Flexibility in the choice of material during formulation 
is important. A wide selection of alginate grades is commercially available and these 
grades differ in their chemical composition, particle size distribution and molecular 
weight (viscosity), giving the formulator a variety of alternatives to choose from, 
depending on the intended application.  
 
 A5. Application of alginates in drug delivery systems 
The desirable attributes of alginate have popularized its use in many fields, 
particularly in the food, pharmaceutical and biotechnological industries. Alginate has 
been, and still is, extensively investigated and has numerous industrial applications 
(Coviello et al., 2006). Various facets of the properties of this polysaccharide had 
been utilized, namely, alginate’s stabilizing, viscosifying, emulsifying, gelling and 
film-forming properties (Gacesa, 1988; Cottrell and Kovacs, 1980). 
 
Sodium alginate is widely used as an encapsulation matrix due to its ability to form 
hydrogels via cross-linking upon contact with polyvalent cations. This unique feature 
has been employed to prepare delivery systems such as beads, microspheres and film-
coatings (Chan et al., 2006; Lee et al., 2005). Sustained-release from such delivery 
systems has met with limited success, particularly with highly water-soluble drugs 
(Chan et al., 1997; Østberg et al., 1994). This was attributed to the highly porous 
nature of the matrices formed (Hills et al., 2000; Klein et al., 1983).  
 
 9
In contrast, sodium alginate matrix tablets have been shown to sustain drug release 
(Moroni and Drefko, 2002; Efentakis and Buckton, 2002). Retardation of drug release 
from such matrices is due to the ability of sodium alginate to form a gel barrier around 
the matrix, which functions as a diffusion barrier. Matrix tablets containing sodium 
alginate as the release-retarding agent have been prepared by direct compression 
(Timmins et al., 1992; Hodsdon et al., 1995; Efentakis and Buckton, 2002; Moroni 
and Drefko, 2002; Holte et al., 2003), granulation (Howard and Timmins 1988; Sirkiä 
et al., 1994; Bayomi et al., 2001) and compression coating (Sirkiä et al., 1994; 
Kaneko et al., 1998) or spray coating (Kaneko et al., 1997). Some of these studies 
have demonstrated the feasibility of preparing alginate matrix tablets industrially. For 
example, alginate matrices could be produced by compaction of alginate granules 
(Timmins et al., 1992) as well as by direct compression (Holte et al., 2003). However, 
work done on alginate matrix tablets is still limited. 
 
A6. Challenges of using alginate matrix tablets as drug delivery systems 
The limited use of alginate as the primary matrix former in tablet systems could be 
attributed to the challenges associated with certain polymer properties. The pH-
dependent solubility of alginate might affect the properties of the diffusion barrier and 
give rise to different drug release rates at different pH. Alginate matrices were 
observed to form non-viscous, porous and tough barrier in acidic conditions. In 
contrast, alginate matrices immersed in water developed viscous gel barriers 
(Efentakis and Buckton, 2002). Since oral dosage forms have to pass through gastric 
and intestinal pH environments, the changes in the gastrointestinal pH could affect the 
ability of alginate matrices to deliver drugs according to zero order kinetics.  
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As mentioned earlier, crack formation or lamination of alginate matrices was 
observed in acidic media (Efentakis and Buckton, 2002). The authors proposed that 
lamination was brought about by destabilization of the gel matrix in the presence of 
theophylline. However, the lamination phenomenon occurred only in the acidic phase, 
suggesting the influence of pH, rather than the destabilizing effect of a drug. Hence, 
further investigation is warranted as this phenomenon could potentially limit the use 
of alginate as sustained-release carriers.  
 
In addition, it was found that sodium alginate has poor compaction properties. In 
general, polymeric materials are unsuitable for tableting because of their elasticity, 
poor flowability and compression properties (Takeuchi et al., 1999). Nevertheless, the 
compaction property of alginate can be improved via particle size modification as 
well as by the incorporation of appropriate binders or via formation of composite 
particles with an easily compressible material (Takeuchi et al., 1999). Investigation on 
the compaction behavior of alginate was not part of this thesis and will not be further 
elaborated. 
 
B. Controlled drug delivery from polymeric matrices 
B1. Significance of controlled drug delivery technology 
Achieving optimal drug concentration at the site of action in the body is essential for 
successful pharmacotherapy. Concentrations beyond the optimal range can lead to 
serious side effects, whereas inadequate drug levels might result in attenuated or lack 
of pharmacodynamic response. Controlled drug delivery technologies can be 
employed to enable continuous drug delivery at a controlled rate for a prolonged 
period of time to achieve a desirable level of therapeutic agent in the blood or target 
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site. The benefits of improved drug safety and efficacy, along with a less demanding 
dosage regimen, lead to enhanced patient compliance, which is an important 
determinant in pharmacotherapeutic success. The diminishing flow of new drugs out 
of the pipelines of pharmaceutical companies and the gradual loss of market share to 
generic drug products provide a strong economic incentive for further research and 
development of such technologies. As new formulations, controlled-release dosage 
forms can help extend the brand name, market exclusivity and patent life of a drug 
(DePalma, 2005).  
 
B2. Matrix systems 
The oral route is the preferred route of drug administration because of safety 
considerations and patient compliance (Chien, 1992). Oral controlled-release systems 
can be classified according to their major rate-controlling mechanisms: membrane- 
controlled reservoir devices, diffusion-controlled matrix systems, biodegradable 
systems and swelling-controlled release systems. The focus of this study is on 
polymer matrix systems, in the form of tablets. Tablets constitute one of the most 
common dosage forms due to their ease of preparation and handling. In a matrix 
system, a drug is homogeneously dispersed in a rate-controlling polymer matrix, 
together with other pharmaceutical excipients. When a hydrophilic polymer matrix is 
placed in an aqueous medium, the hydrophilic colloid component swells to form a 
gelatinous layer at the surface of the dosage form (Fig. 2). This gel layer controls the 
release of drugs by two main mechanisms: (i) diffusion of a water-soluble drug 
through the gel layer and (ii) release of a water-soluble or water insoluble drug by the 




Fig. 2. Mechanism of drug release from a hydrophilic polymer matrix. 
Hydrophilic polymer 
hydrates, swells and forms 
a gel layer. Initial burst 
release of drug occurs. 
Gel layer thickness increases 
as the aqueous medium 
diffuses into the matrix. Drug 
diffuses out through the gel 
layer. 
Dry polymer matrix tablet 
Erosion of gel layer occurs as the 
‘disentaglement concentration a’ 
is reached. 
Water-soluble drug is 
released mainly by diffusion. 
Water-insoluble drug is 
released mainly by erosion. 
a The ‘disentanglement concentration’ is the critical polymer concentration below which 
the polymer chains disentangle and detach from a gelled matrix (Kavanagh and 
Corrigan, 2004). The ‘disentanglement concentration’ is only applicable to disordered 
polymers, which form topological entanglements. In the case of alginates, the 
disentanglement concentration occurs only for matrices consisting of sodium alginate, 
which was in the form of disordered coils. This phenomenon is not applicable for 
calcium alginate matrices, where alginate was converted to an ordered form via cross-
linking with calcium ions (Grant et al., 1973). Ordered polymers do not form 
disentanglements. Instead, calcium alginate gels reach equilibrium with the aqueous 
solvent in the form of a swollen and ‘permanent’ matrix. 
Aqueous medium 
 13
the hydrated surface of the matrix, the core remains dry, providing a reservoir of drug 
and polymer which replenishes the surface gel layer as it dissolves or is eroded. 
 
B3. Mechanisms governing drug release   
Compressed hydrophilic matrix tablets are widely used as modified-release dosage 
forms for oral drug delivery. Much attention has been accorded to studying the drug 
release mechanism from such systems, particularly matrices compressed from 
hydroxypropylmethylcellulose (HPMC), now formally known as hypromellose. The 
processes contributing to drug release from hydrophilic matrices are dynamic and 
complex. Upon contact with aqueous medium, solvent hydrates the matrix surface, 
forming a gel barrier which regulates solvent ingress and drug release. Further solvent 
imbibition into the matrix leads to matrix bulk hydration and drug dissolution, 
followed by matrix swelling and erosion. Ultimately, the drug release profiles from 
such matrices are controlled by the rate of matrix hydration, swelling, drug diffusion 
through the gel layer and matrix erosion (Roy and Rohera, 2002). Essentially, drug 
release from a swellable matrix tablet is governed by the gel barrier formed following 
solvent penetration (Colombo et al., 2000a). The presence of additives may also 
influence the time-dependent microstructure of the matrix during release. For 
example, addition of water-soluble components may increase the porosity of the 
matrix during dissolution. For pH-sensitive polymers such as sodium alginate, pH-
effect has to be considered since it would influence polymer solubility and matrix 
behavior.   
 
Although sodium alginate has a long history of use, the hydration kinetics of sodium 
alginate compacts are not well characterized since alginates are usually formulated 
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and studied as cross-linked microcapsules, beads and films or membranes. In the 
development of matrix systems, it is useful to know which mass transport phenomena 
contribute to drug release. The most important rate-controlling mechanisms in drug 
release are diffusion, swelling and erosion (Kanjickal and Lopina, 2004). Tahara et al. 
(1995) postulated that the rate-limiting mechanism for the release of a highly water-
soluble drug is the rate of solvent penetration, whereas the release of drugs with poor 
aqueous solubility is dependent on matrix erosion. In addition, Colombo et al. (1995) 
reported that solvent transport process into swellable polymer matrices and the 
corresponding dimensional changes had a major influence on drug release from these 
matrices. The amount of drug released showed a linear dependence on the extent of 
releasing area produced by matrix swelling (Colombo et al., 1992). Drug release from 
swellable matrices is controlled by drug diffusion through the gel layer and drug 
transport due to polymer relaxation. The rate of drug diffusion through the gel layer 
depends on drug dissolution and matrix erosion, both affecting the drug concentration 
gradient in gel layer (Colombo et al., 2000b). Drug concentration gradient within the 
gel layer is also affected by the swelling process (Colombo et al., 1999). The polymer 
relaxation process was found to contribute to the translocation of solid drug particles 
within the gel layer towards the matrix erosion front (Bettini et al., 2001). Visual 
evidence of the translocation of insoluble particles within a swelling gel layer was 
reported using confocal laser scanning microscopy (Adler et al., 1999). 
 
The effect of acidic media on alginate matrices warrants an investigation as oral 
tablets will be exposed to the acidic gastric juices. More importantly, sodium alginate 
is a pH-sensitive polymer. Studies demonstrating pH-dependent drug release from 
alginate matrices have been reported (Onsøyen, 1995; Moroni and Drefko, 2002). 
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However, studies elucidating the mechanisms governing pH-dependent hydration and 
drug release from alginate matrices are limited and this provides the impetus for 
further investigations.  
 
B4. Mathematical models describing kinetics of drug release 
A wide spectrum of mathematical models has been developed to describe drug release 
from polymeric matrices. Modeling studies allow the elucidation of underlying mass 
transport mechanisms and offer the possibility of predicting the effect of matrix 
design parameters (shape, size and composition of matrix tablets) on the resulting 
drug release rate (Siepmann and Peppas, 2001). In this study, drug release profiles 
were curve-fitted to commonly used models to characterize and derive drug release 
parameters for comparative purposes. These models include the Higuchi equation, 
power law and zero order equation. 
 
B4.1 Higuchi Equation 
The Higuchi model (Higuchi, 1961, 1963) is commonly used to describe drug release 
from matrix systems. It describes a linear relationship between the cumulative amount 
of drug released and the square root of time, which is an indicator of diffusion 
controlled release. Higuchi (1961) proposed the following equation to describe drug 
release from a planar system consisting of a homogeneous matrix in the form of an 
ointment base containing finely dispersed drug: 
 ss CCADtQ )2( −=   ……………………………….. (1) 
where Q is the amount of drug released after time t per unit exposed area, D is the 
diffusivity of the drug in the homogeneous matrix media, A is the total amount of drug 
present in the matrix per unit volume and Cs is the solubility of the drug in the matrix. 
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For drug release from a planar system composed of a granular matrix, the following 
equation was proposed (Higuchi, 1963): 
tCCADQ ss)2( ετ
ε −=    .……………………………. (2) 
where Q is the amount of drug released after time t per unit exposed area, D is the 
diffusivity of the drug in the permeating fluid, τ is the tortuosity factor of the capillary 
system, A is the total amount of drug present in the matrix per unit volume, Cs is the 
solubility of the drug in the permeating fluid, and ε is the porosity of the matrix. This 
equation described the leaching of drug through intergranular openings in the matrix. 
The Higuchi model was subsequently applied to other types of matrices. Desai et al. 
(1965, 1966) employed inert matrix tablets with only one flat surface exposed to the 
dissolution media. Drug release was found to be linear with square root time. Lapidus 
and Lordi (1968) showed that when drug release was restricted to a planar surface of 
an HPMC matrix tablet, linearity between drug release and square root time was 
observed even though the matrix was not inert. However, linearity of drug release 
with square root of time for the whole tablet was not observed. These studies showed 
that drug release mechanism from whole, non-inert matrix tablets cannot be described 
accurately using the Higuchi equation. 
 
The classical Higuchi equations were derived under pseudo-steady state assumptions 
and generally cannot be applied to practical systems. The assumptions were 
summarized by Siepman and Peppas (2001): (i) the initial drug concentration in the 
system is much higher than the solubility of the drug in the matrix, (ii) mathematical 
analysis is based on one-dimensional diffusion (negligible edge effects), (iii) swelling 
or dissolution of the matrix is negligible, (iv) constant drug diffusivity and (v) perfect 
sink conditions are maintained. Although these assumptions are not valid for most 
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hydrophilic matrices, the Higuchi equation is often employed to analyze drug release 
to gain a rough idea of the underlying drug release mechanism due to its simplicity 
(Siepmann and Peppas, 2001).  
 





 ..………………………………….. (3) 
where Mt and M∞ are the absolute cumulative amount of drug released at time t and 
infinite time, respectively and K is the Higuchi dissolution constant (Costa and Lobo, 
2001). The drug release rate derived from the Higuchi equation predicts a zero 
intercept. However, negative or positive intercepts on the Y-axis might be obtained 
from curve-fitting of dissolution data to the equation. The former indicates a failure of 
the drug delivery system to immediately attain a state of equilibrium diffusion 
described by the Higuchi equation (lag time) while the later represents burst release of 
drug prior to the development of the diffusion-controlling gel barrier (Ford et al., 
1985a; Campos-Aldrete and Villafuerte-Robles, 1997).  
 
B4.2 Power Law 
Swelling leads to moving (diffusion) boundary conditions and this violates one of the 
assumptions of the Higuchi equation. Korsmeyer et al. (1983) proposed the use of a 
simple, semi-empirical model to describe drug release from a single face of a swelling 





 …………………………………… (4) 
where Mt/M∞ is the fractional drug release at time t, k is a kinetic constant 
incorporating structural and geometric characteristics of the dosage form and n is the 
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release exponent indicative of the drug release mechanism. This equation is also 
known as the power law. The use of this equation to analyze drug release from 
swellable polymeric systems was proposed by Peppas (1985) but was limited to one-
dimensional release. Ritger and Peppas (1987a, b) subsequently showed that the 
equation can be used to describe the general drug release behavior of non-swelling 
and swelling polymeric matrices in the form of slabs, spheres and cylinders.  
 
Solute or solvent transport process can be Fickian or non-Fickian, depending on the 
relative rate of diffusion and polymer swelling (macromolecular relaxation). When 
solvent transport is slower than polymer relaxation, Fickian diffusion is observed. In 
contrast, when polymer relaxation is rate-limiting to solvent transport, case II 
transport, or time-independent diffusion, is observed. When the power law exponent 
takes a value of 0.5, Fickian diffusion is the predominant mechanism for drug 
transport. At n = 0.5, the power law corresponds to the Higuchi equation. When n 
=1.0, drug release occurs via case II transport and gives rise to zero order kinetics. 
When n falls between 0.5 and 1.0, anomalous transport occurs. This is attributed to 
the concurrent occurrence of diffusion- and swelling-controlled mechanisms. The 
values of exponent n quoted above apply only to thin films. For matrix tablets 
(cylinders), these values correspond to 0.45 and 0.89, for Fickian and case II 
transport, respectively (Ritger and Peppas, 1987b). The power law equation is only 
valid for the first 60 % of drug release. However, recent work has shown that the 
equation can be applied to the entire release profile (Rinaki 2003). Modified forms of 





−  ……………………………… (5) 
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n   ………………………………. (6) 
where l is the lag time and b is the burst release.  
 
B4.3 Zero Order Equation 
The following equation describes a constant rate of drug release with time: 
tKQQ oot +=   ………………………………… (7) 
where Qt is the amount of drug released at time t, Qo is the initial amount of drug in 
the solution and Ko is the zero order release constant (Costa and Lobo, 2001). In 
addition to Case II transport, other mechanisms also give rise to linear drug release 
kinetics. In swellable-erodible polymer matrices, constant drug delivery rate can be 
achieved when a constant gel layer thickness is attained by synchronization of the 
swelling and eroding fronts (Conte et al., 1988; Baveja et al., 1987). Constant drug 
release rate was also observed with matrices consisting of low viscosity polymer 
where polymer dissolution controlled the rate of drug release (Möckel and Lippold, 
1993).  
 
C. Factors affecting the performance of polymer matrices 
C1. Physicochemical properties of the drug 
The release of a drug from a dosage form is dependent on its physicochemical 
properties, such as its aqueous solubility and particle size. The aqueous solubility of a 
drug affects not only its dissolution rate, but also its release mechanism from a 
polymer matrix. Water-soluble drugs are released primarily via diffusion through the 
gel layer while a water-insoluble drug is released predominantly by erosion of the gel 
layer (Alderman, 1984). In addition to drug solubility, the relative contribution of 
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each release mechanism to the overall drug release process is also influenced by the 
physical properties of the diffusion barrier that forms around the tablet. This 
proposition was investigated by Hodsdon et al. (1995) using sodium alginate matrices. 
It was observed that the release of a highly water-soluble drug, chlorpheniramine 
maleate, was significantly faster in simulated gastric fluid (SGF) than in simulated 
intestinal fluid (SIF). The opposite effect was observed for hydrochlorothiazide, a 
poorly water-soluble drug. This was explained in terms of the different alginate 
barrier structure formed when hydrated under different pH conditions. The hydrated 
surface layer formed by alginate matrix in SGF was observed to be porous and 
particulate in nature, in contrast to the highly viscous and continuous gel layer formed 
in SIF. Hence, the release of chlorpheniramine maleate, which relies mainly on 
diffusion, was faster in SGF due to the greater porosity of the gel barrier, enabling 
faster solute egress. Hydrochlorothiazide was released more rapidly in SIF due to 
greater susceptibility of the viscous gel barrier to mechanical attrition, compared to 
the tough, rubbery ‘rind’ formed in SGF which was more erosion-resistant.  
 
The influence of drug particle size is dependent on its aqueous solubility. The drug 
particle size was noted to be important in the case of water-insoluble drugs, but for 
water-soluble drugs, the influence of particle size was only noticeable at low levels of 
polymer content and when the drug particle size was large (250-500 µm) (Ford et al., 
1985b). It was noted that an increase in drug particle size of propranolol or 
aminophylline from 63 to 250 µm did not significantly affect drug dissolution rate 
from HPMC matrices (Ford et al., 1985b). However, when large propranolol particles 
were used at low polymer content (26.3 %), release rate increased significantly due to 
increased matrix porosity brought about by the rapid dissolution of drug particles. 
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Velasco et al. (1999) observed that drug particle size affected the release mechanism 
of diclofenac sodium from HPMC matrices. It appeared that the release of smaller 
drug particles depended more on the diffusional process since the smaller particles 
dissolved more easily when wetted by the dissolution media. Larger drug particles 
would dissolve less readily and relied more on erosion of the gel layer to be released.   
 
The release of a drug with charged groups from matrices composed of anionic or 
cationic polymers might be affected by drug-polymer interaction. Such interactions 
had been proposed to result in slower release of cationic chlorpheniramine maleate 
compared to anionic sodium salicylate from sodium alginate matrices (Stockwell and 
Davis, 1986). Viscosity studies using dilute polymer and drug solutions showed the 
formation of a ‘jelly-like’ precipitate, indicating complexation of alginate and 
chlorpheniramine maleate (Stockwell and Davis, 1986). However, electrostatic 
interactions are sensitive to the presence of other ions in solution. Moreno-Villoslada 
et al. (2005) showed that chlorpheniramine maleate interacted with alginate at pH 7.5 
in the absence of sodium chloride, but, the interactions were prevented in the presence 
of sodium chloride due to screening effects and competition of the large excess of 
sodium ions to bind with the polyelectrolyte surfaces.  
 
C2. Polymer factors  
C2. 1 Polymer concentration 
The effect of polymer concentration on drug release had been widely reported for 
HPMC matrices (Alderman, 1984; Rekhi et al., 1999; Gao et al., 1996; Skoug et al., 
1993). As a general rule, increasing the proportion of hydrophilic polymer decreased 
the drug release rate (Alderman, 1984; Rekhi et al., 1999). The most common reason 
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used to explain the effect of polymer content on drug release was that an increase in 
polymer content resulted in increased viscosity of the gel matrix, causing a reduction 
in the effective diffusion coefficient of the drug (Skoug et al., 1993). Gao et al. (1996) 
attributed the reduction in drug release rate with increasing HPMC content to the 
reduction in drug diffusivity with an increase in polymer concentration. However, a 
change in diffusion coefficient could not fully explain the difference in drug release 
rate. Skoug et al. (1993) noted that the extent of modulation in drug release rates was 
not proportional to the changes in formulation composition. In another study, it was 
observed that drug release rate decreased with an increase in HPMC content up to 20 
% polymer content. Further increase in polymer content had marginal influence in 
retarding drug release (Wan et al., 1993).  Given the complexity of swellable 
matrices, it is unlikely that a change in diffusion coefficient is entirely responsible for 
the change in drug release rate. Other factors, such as differences in water penetration 
rate, water absorption capacity and swelling, which result from changes in polymer 
content, could have played a part in modulating drug release (Skoug et al., 1993).  
 
C2.2 Physicochemical properties of the polymer 
C2.2.1 Polymer particle size 
Quick formation of a diffusion barrier is necessary to achieve controlled drug release 
from polymer matrices. The polymer used must hydrate sufficiently fast to form a gel 
layer before the soluble contents of the matrices dissolve prematurely. One factor that 
affects the polymer hydration rate is the particle size of the polymer (Alderman, 
1984). Alderman observed that tablets made with the coarsest HPMC particles did not 
give adequate sustained release of drug compared to tablets made using smaller size 
fractions of HPMC. In another study, it was reported that the polymer particle size 
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affected the lag time preceding drug release (Velasco et al., 1999). As the particle size 
increased, the lag period decreased. For tablets made using coarser polymer fractions, 
burst release was observed, indicating that drug release occurred prior to the 
establishment of the gel barrier. The increased drug release rate and increased burst 
effect with larger polymer particle size were also reported by another research group 
(Campos-Aldrete and Villafuerte-Robles, 1997). In a recent study, it was proposed 
that an increase in the number of polymer particles could lead to higher degree of 
chain entanglement, forming a less porous and more tortuous diffusion barrier for 
drug release (Heng et al., 2001). For similar polymer content, a reduction of particle 
size is accompanied by numerical increase in polymer particles. This enhances the 
availability of adjoining particle contact points, favoring polymer chain entanglement 
for the formation of a gel barrier. A study on matrices containing spray-dried 
composite particles of lactose and sodium alginate showed marked drug release 
retardation from these matrices compared to matrices containing physical mixtures of 
sodium alginate and lactose (Takeuchi et al., 1998). It was found that the particle size 
of the spray-dried composite particles was much smaller than the sodium alginate 
particles. The even dispersal of sodium alginate in the composite particles, coupled 
with its small particle size resulted in a more sustained drug release. 
 
C2.2.2 Polymer viscosity 
Upon hydration of a hydrophilic polymer matrix, the polymer absorbs water and 
swells to form a viscous gel barrier. Water-soluble drug molecules are mainly 
transported across the gel barrier via diffusion. The influence of viscosity on drug 
diffusion can be observed from the Stokes-Einstein equation (Kuu et al., 1992). 
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According to this equation, the diffusion coefficient, D, of the solute molecules is 
inversely proportional to the viscosity of the media: 
Ar
RTD
oΝ= πη6   …………………………………. (8) 
where R is the gas-law constant, equal to 8.314 x 107 g-cm2/s2 -gmol-K; η is the 
viscosity of the solvent in g/cm-s; No is the Avogadro’s number, equal to 6.023 x 
1023/ g-mol; T is the absolute temperature in K; and rA is the radius of the spherical 
solute molecule. A modification of the Stokes-Einstein equation was introduced by 
Sutherland to allow more reliable prediction for smaller solute molecules. The 

















  ………………………… (9) 
where β is the coefficient of sliding friction between the solute molecule and the 
solvent molecule. Hence, the higher the gel barrier viscosity, the lower the solute 
diffusion coefficient and the lower the rate of drug release.  
 
The viscosity of the gel barrier depends on the polymer molecular weight (viscosity) 
as well as the polymer content in the matrix. An increase in the viscosity of HPMC in 
matrix formulations with 10 % polymer content resulted in decreased drug diffusion 
rate due to enhanced gel layer viscosity. In addition, greater viscosity of the gel layer 
reduced its erodibility (Alderman, 1984). Wan et al. (1992) observed that the square 
of dissolution T50 % varied proportionally with the solution viscosity of the polymer 
and proposed an equation relating the two variables. Viscosity effect was most 
apparent at 25 % HPMC content and gradually leveled off with increasing polymer 
content. Similarly, Campos-Aldrete and Villafuerte-Robles (1997) reported that the 
effect of HPMC viscosity grade on drug release rate was only observed at 10 % 
 25
polymer content and was masked at higher (20 and 30 %) polymer ratios. In contrast, 
Bonferoni et al. (1992) found that polymer viscosity did not significantly influence 
the release profile of salbutamol sulphate from matrices containing different viscosity 
grades of HPMC. However, the high HPMC content (45.2 %) in the matrices could 
have masked the viscosity effect. Bettini et al. (1994) also reported that matrices 
containing three different viscosity grades of HPMC did not show significant 
differences in drug release and the polymer concentration used was 24.5 %. These 
findings showed that the influence of polymer viscosity on drug release was only 
important at lower polymer concentrations. These studies were conducted using 
HPMC, which is pH-insensitive. The solubility of alginate is pH-dependent. At acidic 
pH, the soluble sodium alginate is converted to insoluble alginic acid and the role of 
polymer viscosity at acidic pH is uncertain and requires further investigation. 
 
C2.2.3 Chemical composition of the polymer (alginate) 
The mannuronic/guluronic acid (MG) ratio of alginates can affect drug release from 
sodium alginate matrices. Press-coated ibuprofen tablets containing G-rich alginates 
slowed down drug release more than tablets containing M-rich alginates (Sirkiä et al., 
1994). Similar observations were made in other studies using matrix tablets (Timmins 
et al., 1992) and capsules (Veski and Marvola, 1993) containing sodium alginate of 
different MG ratio. G-rich alginates formed more rigid gels when hydrated and such 
gels might be less prone to erosion (Veski and Marvola, 1993). These studies were 
carried out at near neutral pH. The impact of MG ratio on drug release from alginate 




C3. Type of excipients 
Alderman (1984) found that the use of insoluble excipients can drastically change the 
dissolution rates of tablets. In the model formulation, incremental amounts of lactose 
were replaced with microcrystalline cellulose, an insoluble but swellable excipient. 
The increasing levels of disintegrant changed the dissolution profile by accentuating 
the burst effect. In addition, as little as 10% of the insoluble and non-swelling 
excipient, dicalcium phosphate was reported to completely destroy the sustained 
release effect of HPMC matrix. This occurred because the gel layer was unable to 
swell uniformly. The presence of non-swelling particles in a swelling matrix caused 
internal stress and resulted in crack formation in the matrix, causing the tablet to 
disintegrate prematurely. However, this phenomenon was not observed in other 
studies. Rekhi et al. (1999) reported that a change of excipient from lactose to 
dicalcium phosphate resulted in decreased drug release rate from HPMC matrices. 
This was in agreement with the findings of Williams III et al. (2002). It was proposed 
that the dissolution of soluble lactose caused an increase in the porosity and a 
subsequent reduction in the tortuosity of the gel barrier, resulting in greater drug 
diffusion from the matrix. In addition, it was found that the use of binary mixtures of 
lactose and dicalcium phosphate produced release profiles of intermediate duration, 
indicating the usefulness of insoluble excipients in modifying drug release behavior. 
 
The incorporation of calcium-containing excipients into alginate matrix formulations 
can bring about cross-linking of the alginate polymer. Other researchers have 
employed cross-linking to lower drug release rates from alginate matrix tablets 
(Azarmi et al., 2003; Nokhodchi and Tailor, 2004). Azarmi et al. (2003) reported 
reduced drug release rates at pH 7.4 with increasing calcium chloride dihydrate 
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concentration (0.75 to 19 % w/w) incorporated into alginate matrices. Nokhodchi and 
Tailor (2004) also reported slower drug release with addition of calcium chloride 
dihydrate at pH 7.5. However, this was only observed at high (21 % w/w) calcium salt 
content. At intermediate calcium salt concentrations (11.8 and 16.7 % w/w), initial 
burst release was enhanced followed by slower drug release. Drug release was rapid at 
low calcium salt concentration (3.8 % w/w) and this was attributed to insufficient 
cross-linking to produce an insoluble gel barrier. In contrast, another study reported 
enhanced drug release from alginate matrices containing calcium gluconate at pH 7.4 
(Güngör et al., 2003). However, the impact of calcium gluconate was not clearly 
elucidated as the amount of sodium alginate was not kept constant between 
formulations. In addition, the use of microcrystalline cellulose as the diluent could 
have interfered with alginate-calcium interaction. In yet another study, calcium 
alginate-coated tablets were found to produce zero-order drug release in distilled 
water (Bhagat et al., 1991). These tablets were produced by immersing calcium 
acetate tablets in 1 % w/w sodium alginate solution for 10-70 min. The coated tablets 
were subsequently treated in 50 % calcium chloride solution and rinsed with absolute 
ethanol to improve the rigidity of the coat. Sodium alginate in combination with 
dibasic calcium phosphate and tri-sodium phosphate sustained the release of acetyl 
salicylic acid for up to 16 h at simulated gastrointestinal pH (Holte et al., 2003). 
However, the effect of these additives was not clear as no comparison was made with 
sodium alginate control matrices. To date, studies on drug delivery from such systems 
in gastrointestinal pH conditions are limited. The impact of cross-linking on the 




C4. Matrix porosity 
Changes in compression force appeared to have minimal effect on drug release from 
matrix tablets once a critical hardness is achieved. An increase in drug release was 
only observed when the tablets were too soft (Rekhi et al., 1999). Sodium alginate 
matrices prepared at three compression force levels over the range 1.5-5 tons were 
found to produce overlapping dissolution profiles, indicating that compression force 
over the stated range did not affect drug release (Timmins et al., 1992). Other studies 
using HPMC matrices showed similar findings (Velasco et al., 1999; Bettini et al., 
1994). It is assumed that variation in compression force is closely related to changes 
in the porosity of the matrix tablets. Hence, the lack of influence of compression force 
indicates that the initial porosity of the matrix does not affect the overall drug release. 
Drug release is expected to be more closely related to the porosity of the hydrated gel 
layer, which is independent of the initial matrix porosity, since it is the gel layer that 
controls the diffusion of drug. The relative insensitivity of drug release from swellable 












II. HYPOTHESES AND OBJECTIVES 
Many different grades of sodium alginate are commercially available and these grades 
vary in their particle size, molecular weight and chemical composition. These 
variations may have an impact on drug release behavior, and yet there has been no 
substantial study to determine the influence of a wide range of alginate grades on the 
drug release properties of alginate matrix tablets. These properties have been shown 
to affect the drug release performance of polymer matrices, particularly hypromellose 
matrices. Hence, it was hypothesized that alginate particle size, viscosity and 
chemical composition can be employed to modify drug release from alginate matrix 
tablets at both acidic and near-neutral pH. 
 
The development of cracks in alginate matrices at acidic pH can compromise the 
function of the diffusion barrier, resulting in the loss of controlled drug release. The 
occurrence of cracks at acidic pH suggests that crack formation was associated with 
the conversion of sodium alginate to alginic acid. It had been suggested that calcium 
alginate gel is stronger than the corresponding alginic acid gel (Draget et al., 2006 and 
1994) and might be less susceptible to mechanical damage due to swelling pressure. 
In addition, the conversion of calcium alginate to alginic acid at pH < 3 did not 
change the morphology or structure of alginate beads (Ibáñez and Umetsu, 2002; 
Østberg et al., 1994). Hence, it was hypothesized that crack development can be 
impeded by increasing the micro-environmental pH within alginate matrices or by the 
formation of calcium alginate barrier via cross-linking, enabling sustained drug 
delivery to be achieved at acidic pH. 
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To test the abovementioned hypotheses, studies were carried out with the following 
objectives: 
(1) investigate the influence of sodium alginate particle size, viscosity and MG ratio 
on the drug release performance and hydration behavior of alginate matrices, 
(2) investigate the impact of the type and amount of calcium salts as well as the 
availability of internal or external calcium ions and the MG ratio of alginate on the 
physical integrity and drug release performance of alginate matrices, and 
(3) investigate the effect of the type and amount of pH-modifiers on drug release 
performance of alginate matrices, matrix micro-environmental pH and matrix 
morphology using alginate matrices that had shown extensive crack formation.  
 
















A. MATERIALS  
 
A1. Sodium alginate 
 
Seventeen grades of sodium alginate (ISP-Alginates Industries, USA) were used. 
These can be classified into two groups, M-rich and G-rich alginates. M-rich alginates 
consist of approximately 60 % mannuronic acid and 40 % guluronic acid while the G-
rich alginates have typical values of about 37 % mannuronic acid and 63 % guluronic 
acid (Lawson, 2003). The M-rich alginates used were Keltone HVCR, Keltone 
LVCR, Kelvis, Kelcosol, Manucols (LB, LF, DH, LKX, SS/LL and DMF); G-rich 
alginates used were the Manugels (LBA, LBB, GHB, GMB, DJX, DMB and DPB).  
 
 
A2. Model drug 
Chlorpheniramine maleate (BP grade, China), a water-soluble model drug, was milled 
prior to use (median particle size ~ 30 µm). Chlorpheniramine maleate was used as it 
has high aqueous solubility that is relatively similar at both acidic and neutral pH (650 
g/L and 584 g/L at pH 1.2 and 6.8, respectively); this would ensure that drug release 
is primarily dependent on the properties of the matrix and not on drug solubility. 
 
A3. Tablet excipients 
Lactose (Pharmatose 200M, DMV, Netherlands) was used as the filler and 







A4.1 Calcium salts 
The types of calcium salts used were dibasic calcium phosphate (Emcompress, 
Edward Mendell, USA), calcium gluconate monohydrate (Merck, Germany), calcium 
carbonate (Merck, Germany) and calcium chloride dihydrate (Merck, Germany).  
 
A4.2 pH-modifiers 
The pH-modifiers employed were alkaline salts, namely, sodium acetate (BDH 
Laboratory Supplies, England), sodium bicarbonate (Sino Chemical, Singapore) and 
tri-sodium phosphate dodecahydrate (Merck, Germany). Sodium chloride (Merck, 
Germany) was used for comparative purpose.  
 
A5. Dye and pH-indicators 
Methylene blue, a water-soluble dye, was used as a marker for liquid penetration into 
the matrix. Bromophenol blue and phenolphthalein, each with color transition range 
of pH 3 to 4.6 and pH 8 to 10, respectively, were used to visually indicate pH-change 
within the hydrated area of the matrix.  
 
A6. Chemicals for dissolution media preparation 
Hydrochloric acid (HCl, 37 %, Merck, Germany) and tri-sodium phosphate 
dodecahydrate (Na3PO4.12H2O, Merck, Germany) were used for dissolution media 
preparation. Sodium chloride (Merck, Germany) was used in the investigation on the 





B1. Particle true density determination 
The true volumes of material used for tableting were measured using a helium 
pycnometer (Penta-pycnometer, Quantachrome, USA) according to the USP method 
(chapter < 699 >). The powders were oven-dried and cooled in a desiccator prior to 
carrying out measurements. The measurements were repeated until 3 consecutive 
readings did not vary by more than 0.1 %. The true density of a powder, ρt, was 
obtained by dividing the sample mass taken after pycnometric measurement, m, by the 
sample true volume, Vt, according to the following equation:  
t
t V
m=ρ …….……………………………. (10) 
 
B2. Sieving 
Samples of sodium alginate (Manucol LB and Manucol SS/LL) were classified into 
different size fractions using 20 cm diameter sieves (Endecotts, UK). A nest of sieves 
was assembled in decreasing aperture size according to √2 progression (250, 180, 125 
and 90 μm) and vibrated at an amplitude of 1.5 mm for 20 min with a sieve shaker. 
 
B3. Particle size reduction 
B3.1 Size reduction of model drug 
Chlorpheniramine maleate was introduced into the feeder of a pin mill (12-pin, Retsch 
ZM 1000, Germany) fixed with a 0.5 mm metal mesh and milled at 10 000 rpm in 1 




B3.2 Size reduction of sodium alginate 
Cryogenic milling of sodium alginate (Manucol LB and Manucol SS/LL) was carried 
out using an impact pulverizer mill with a 0.3 mm mesh (Goblin, Nara, Japan) at 
about -60 °C with liquid nitrogen. For Manucol LB, milling speeds of 7500, 10000, 
12500 and 15000 rpm were used to obtain alginate of different particle size. Milling 
was performed in duplicates for each milling speed. Manucol SS/LL was milled at 
12500 rpm. 
 
B4. Particle size determination 
The particle size distribution of sodium alginate and chlorpheniramine maleate was 
determined by laser diffractometry (Coulter LS 230, USA) using the dry powder 
module. At least two determinations were carried out for each batch. The particle size 
was expressed as the volume median diameter of the particles, which is the diameter 
below which 50 % by volume of the particles reside.  
 
B5. Viscosity determination 
The kinematic viscosities of 1 % w/w solutions of the different alginate grades were 
determined at 37°C using the BP procedure with the aid of suspended-level 
(Ubbelohde) viscometers (BP, 2004).  The test solution was placed into the 
viscometer where it flowed down a capillary tube under the influence of gravity. The 
time taken for a given volume of the liquid to pass a graduation mark was noted. 
Kinematic viscosity, v, was calculated from the equation 
 v = Kt   ………………………………… (11) 
where t is the flow time in seconds and K is the nominal viscometer constant. The 
alginate solutions were prepared one day in advance and equilibrated to the required 
 35
temperature for 30 min before taking measurements. The average of not fewer than 
three readings was taken as the flow time of the solution being examined, provided 
that consecutive readings did not differ by more than 1 %. 
 
B6. Interaction studies by viscometry 
Viscosity studies using 0.1 % w/w Manugel DMB solutions with or without calcium 
salt additives were performed to examine the interaction between sodium alginate and 
calcium ions. A U-tube viscometer (Size A, BP) was used to determine the flow times 
of sodium alginate solutions at 37 °C. Dilute sodium alginate solutions were prepared 
in pH 6.8 phosphate buffer or deionized water. Dibasic calcium phosphate or calcium 
carbonate was added to the alginate solution in excess under constant agitation using a 
magnetic stirrer. Soluble calcium chloride was used as a positive control. An 
equivalent amount of calcium chloride was dissolved in half the amount of solvent 
required before adding to double-strength sodium alginate solution under constant 
agitation. The samples were then immersed in a shaker water bath at 37 °C for 2 h, 
followed by centrifugation at 3000 rpm for 15 min. The supernatant was collected and 
its flow time at 37 °C was determined in triplicate. Preliminary investigations showed 
that centrifugation did not significantly affect the flow time of alginate solution (Table 
1).  
 
Table 1. Effect of centrifugation on flow time of alginate solution. 
Calcium salt additive Flow time (min) 
 Before centrifugation After centrifugation 
   
None (negative control) 7.59 7.77 
Calcium carbonate 7.62 7.58 
Dibasic calcium phosphate 7.71 7.75 
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B7. Solubility determinations 
B7.1 Solubility of chlorpheniramine maleate 
Excess amount of chlorpheniramine maleate was added to conical flasks containing 
0.1 N HCl (pH 1.2) or pH 6.8 phosphate buffer, respectively. The samples were 
shaken for 24 h at 37 °C in a shaker water bath. Samples of the supernatant were 
collected, diluted appropriately, filtered through 0.45 μm filter membrane and assayed 
spectrophotometrically (UV-1201, Shimadzu, Japan) at 266 nm for samples in pH 1.2 
solution and 262 nm for samples in pH 6.8 solution, respectively. Solubility 
determinations were conducted in duplicates. 
 
B7.2 Solubility of dibasic calcium phosphate 
The solubility of dibasic calcium phosphate at pH 1.2 was estimated gravimetrically. 
A known amount of dibasic calcium phosphate was added to a conical flask 
containing 0.1 N HCl (pH 1.2) and agitated for 24 h at 37 °C. The suspension was 
filtered and the residue collected and dried at 60 °C until constant weight. The 
solubility was estimated by calculating the amount of salt dissolved at pH 1.2. 
 
B8. Preparation of matrix tablets  
The formulations of alginate matrices used are given in Table 2. Matrices were 
prepared in batches of 50 or 100 tablets. The weighed amounts of material were 
premixed geometrically using a spatula and subsequently randomly mixed in a bag for 
10 min. The lubricant, magnesium stearate was then added, followed by further 
mixing for 2 min. The resultant powder mixture was individually weighed, transferred 
into the die and compressed into matrix tablets using a single punch tableting machine 
(F3, Manesty, UK) with 9.5 mm diameter flat punches. Matrix tablets with porosities 
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of 0.1 to 0.3 were made. The tablets were stored in a desiccator for at least 3 days to 
allow for tablet relaxation before use. Tablets with weight variation within ± 5 % of 
the target weight were selected for subsequent studies. 
 




ρε −=1 ……..…………………………. (12) 
where ρapp and ρT are the apparent and true tablet density, respectively. The apparent 
density of the tablet, ρapp, is calculated from: 
app
app V
W=ρ …….…………………………. (13) 
where W is the weight of the tablet and Vapp is the apparent volume of the tablet.  
The apparent volume of the tablet is obtained using the formula: 
Vapp = πr2h   ……………………………… (14) 
where r and h are the radius and thickness of the tablet, respectively. 
True density of the tablet, ρT, is calculated from:  
ρT = aρ1 + bρ2 + cρ3 +….. + zρn  ………………….. (15) 
where a, b, c and z are the fractions of components 1, 2, 3 and n in the formulation 
consisting of material having true densities of ρ1, ρ2, ρ3 and ρn, respectively. Using the 
above equations, the tablet thickness corresponding to the required porosity can be 
calculated as 
))(1(2 Tr






Table 2. Formulations of alginate matrices 
 
 
B9. Preparation of calcium alginate-coated matrices 
Each Manugel DMB control matrix (without calcium salt) was immersed in 500 ml of 
0.1 or 0.01 M calcium chloride solution with gentle stirring at 30 rpm and 25 ºC for 
0.5, 1 or 1.5 h. The cross-linked matrices were then oven-dried at 40 ºC overnight and 




Amount of material per tablet (mg) System Type of 
matrix 
Alginate 
grade Alginate Drug Additive Lactose Lubricant Total 
 
















35 40 - 271.5 3.5 350 
30 % 
alginate 





























306.5 40 18.43 - 3.7 368.6 
10 % 
additive 





























































B10. Drug release studies  
Dissolution media were freshly prepared using distilled water and deaerated by 
passing through a sintered-glass filter under vacuum. Drug release from matrix tablets 
was evaluated by dissolution testing using USP Method A (chapters <711> and 
<724>) at 50 rpm and 37 ± 0.5 °C for up to 8 h with paddles (USP Apparatus II, 
Vankel, USA). Dissolution test was first carried out in 750 ml of 0.1 N hydrochloric 
acid (pH 1.2) for 2 h and pH of the medium was then adjusted to 6.8 by adding 250 
ml of 0.2 M sodium phosphate solution, preheated to 37 °C. Either 2 M hydrochloric 
acid or 2 M sodium hydroxide was used for minor adjustment of the pH of the 
dissolution media when necessary.  
 
Dissolution tests for some parts of the study were also carried out at pH 6.8 buffer 
alone, which consisted of 750 ml of 0.1 N hydrochloric acid and 250 ml of 0.2 M 
sodium phosphate, adjusted to pH 6.8 ± 0.1 with 2 M hydrochloric acid. In the 
investigation on the effects of external calcium ions on the drug release behavior of 
alginate matrices, dissolution studies using control matrices (without calcium salt 
additives) were carried out in calcium chloride solutions. Appropriate quantities of 
calcium chloride dihydrate were dissolved in distilled water to prepare 0.01, 0.05, 0.1, 
0.2 and 0.5 M solutions. Dissolution of control matrices was also carried out in 
sodium chloride solutions at 0.03, 0.3, 0.6 or 1.5 M concentration to investigate the 
effect of ionic strength. Dissolution of alginate matrices was also carried out in 
distilled water. 
 
At suitable time intervals, samples were collected and assayed spectrophotometrically 
(UV-1201, Shimadzu, Japan) at 266 nm for samples in acid, and at 262 nm for 
 40
samples in pH 6.8 buffer or water (or calcium chloride or sodium chloride solutions), 
using the appropriate Beer’s plots (Table 3). For each formulation, at least triplicate 
dissolution runs were carried out and the averaged results reported.  
 
 
Table 3. Beer’s plots for the absorbance of chlorpheniramine maleate in different 
media 
 
Dissolution media Wavelength 
(nm) 
Beer’s plot a Coefficient of 
determination, R2 
    
0.1 N HCl (pH 1.2) 266 Y=0.1984X 0.9999 
 
0.1 N HCl+0.2 M Na3PO4  (pH 6.8) 262 Y=0.1318X 0.9996 
 
Distilled water 262 Y=0.1355X 1.0000 
 
 




B11. Measurement of liquid transport by gravimetry and image analysis  
Sodium alginate matrices containing methylene blue or bromophenol blue were used 
to study liquid penetration as well as to visualize and quantify matrix micro-
environmental pH. Each matrix tablet was placed on a stainless steel mesh to facilitate 
matrix retrieval. These matrices were subjected to the conditions employed in the 
dissolution test. At appropriate time intervals, hydrated matrices were retrieved from 
the liquid medium, gently blotted to remove excess medium and weighed. The change 








WW −=100   ………………….. (17) 
 
where Ww and Wi are the wet and initial weights of the matrix, respectively. 
 
The matrices were then immersed in liquid nitrogen for 5 to 10 s to prevent matrix 
deformation upon cutting and halt liquid movement for accurate determination of 
matrix and hydrated layer dimensions. This freezing time hardened the external gel 
layer without completely freezing the matrix, which would otherwise fracture upon 
cutting. Comparison of matrix dimensions before and after freezing showed that cryo-
treatment of matrix tablets did not affect axial or radial swelling profiles of alginate 
matrices (Appendix 1, page 175). The partially-frozen matrices were then sectioned 
axially with a sharp blade. Images of cross-sectioned matrices were captured with a 
digital camera (E-300, Olympus, Japan) and analyzed using an imaging software 
(Image-Pro Plus, Media Cybernetics, USA). The hydrated layer was stained blue and 
the dry core appeared yellowish with specks of dark blue particles. At least 3 matrices 
were measured for each time point. For each matrix, the dimensions of the entire 
matrix and dry core were measured in the axial and radial directions (Fig. 3). Matrix 
swelling was expressed as a percentage of the initial diameter, Di, or initial thickness, 
Hi, of the matrix: 




HH −=100  …………………… (18) 




DD −=100   .….….…………… (19) 
where H and D are the swollen tablet height and diameter, respectively. Aspect ratio 
was calculated as the ratio of the swollen tablet diameter to swollen tablet height: 
Aspect ratio
H










                          
 
Fig. 3. Axial cross-section of hydrated matrix showing how measurements were made 
for (A) matrix with uniform swelling and (B) matrix with cracks/lamination. Matrices 
in (A) and (B) contained methylene blue or bromophenol blue, respectively. 
 
D = Swollen tablet diameter; d = Core diameter; H = Swollen tablet height; h = Core 
height. Swollen tablet diameter, D, for matrix (B) was determined from the axial (top) 
view and reported as an average value determined by the software.  









The hydrated layer thickness in the axial or radial directions was calculated as 
follows:  
Axial hydrated layer thickness = H – h …………………… (21) 
Radial hydrated layer thickness = D – d ...………………… (22) 
where h and d are the core height and core diameter, respectively. The hydrated and 
apparent dry core areas were reported as the actual area. The hydrated area was also 
reported as a percentage of the entire cross-sectional area:  
% Hydrated area = 100. (Hydrated area / Entire cross-sectional area) ….. (23) 
 
Hydrated matrices retrieved at each time point were oven-dried at 60 ºC to constant 
weight to determine the extent of matrix erosion which was calculated as follows: 
 




WW −=100  …………………… (24)                    
 
where Wi and Wd are the initial and the final dry weights of the matrix, respectively. 
Liquid uptake per unit weight of matrix remaining was also calculated at each time 
point to account for the effect of matrix erosion. Hence, liquid uptake per unit weight 
of matrix remaining was computed according to the following equation: 












B12. Data analysis 
B12.1 Analysis of drug release data 
The kinetics of drug release from matrix tablets were characterized using suitable 
mathematical models or by using model-independent dissolution parameters. The rate 
of drug release was determined by curve-fitting dissolution data to the zero order or 
Higuchi square root equations using GraphPad Prism 3.0 for comparative purposes. 
The Higuchi and zero order models represent two limit cases in the transport and drug 
release phenomena (Costa and Lobo, 2001). While the power law model can be a 
decision parameter between these two models, the rate indicating parameter, k, cannot 
be compared if the mechanism indicating parameter, n, is different among the 
different formulations being compared, as the profiles follow different order of 
release. The goodness-of-fit of dissolution data to the two models were compared 
using GraphPad Prism 3.0. The parameters used to compare the goodness-of-fit of the 
dissolution data to the models were R2, absolute sum of squares (sum of the squares of 
the vertical distances of the points from the curve, and the standard deviation of the 
residuals (standard deviation of the vertical distances of the points from the line). 
Since both zero order and the Higuchi model have the same number of variables, the 
model that gives higher R2, lower absolute sum of squares and lower standard 
deviation of the residuals indicates better fit to that equation. A runs test was 
performed concurrently to evaluate whether the curve deviates systematically from 
the data (Motulsky, 2004). A low P value (P < 0.05) indicates significant deviation of 
the dissolution data from the curve. Analysis of variance (ANOVA) was carried out to 
compare the rate of drug release at α = 0.05 using SPSS version 11.0, followed by 
post hoc tests when P < 0.05 where more than two group means were compared. The 
Dunnett test or Bonferroni test was performed when comparison was made against the 
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control or against each experimental group, respectively. The model-dependent 
approach is recommended for the ‘dissolution data rich’ scenario, defined as 
consisting of at least 4 or more dissolution data points (Sathe et al., 1996). Dissolution 
parameters T25% and T75%, each representing the time taken in minutes to achieve 25 
% and 75 % drug release, respectively, were also used to describe drug release 
kinetics, particularly when the number of data points were insufficient for modeling 
studies, or when the profiles under comparison fit different models of release. 
 
Curve-fitting to the Higuchi and zero order models can also give an indication of the 
drug release mechanism. However, power law is recommended for determination of 
drug release mechanism from non-inert matrices. Drug release parameters were 
reported as mean values and the standard errors of the mean values were written in 
parentheses. Mean % drug release was plotted against time and the standard errors of 
the mean were represented by vertical bars. 
 
Besides using ANOVA to compare dissolution parameters, drug release profiles can 
also be compared using the similarity factor (Moore and Flanner, 1996). The 
similarity factor (f2) is a logarithmic reciprocal square root transformation of the sum 
of squared error of differences between the test (Tj) and reference formulation (Rj) 
over all time points: 
f2 = 50. log {[1 + (1/n)Σ=
n
j 1
 wj│Rj – Tj │2 ]-0.5 .100} ………… (26) 
where wj is an optional weight factor and n is the number of sampling time points. It 
is a measurement of the similarity in the percent dissolution between the curves. The 
use of similarity factor has been adopted by the FDA as an assessment criterion of 
similarity between two in vitro dissolution profiles (FDA, 1997a, b). A convenient 
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critical value of 50 is derived for similarity of dissolution profiles based on average 
difference of 10 % at all sampling time points (Shah et al., 1998). Two dissolution 
profiles are considered equivalent if f2 values range from 50 to 100. The similarity 
factor was reported to be too liberal in concluding similarity between dissolution 
profiles (Costa and Lobo, 2001). It was reported that ANOVA-based and model-
dependent approaches have narrower limits and are more discriminative than the f-
factors (Yuksel et al., 2000). In addition, it does not take into consideration the shape 
of the dissolution profile and variation in spacing between sampling times (Costa and 
Lobo, 2001). Hence, this approach was not used in this study. 
 
B12.2 Analysis of data obtained from hydration studies 
Similarly, the profiles of percent liquid uptake, swelling, hydrated area and matrix 
erosion were curve-fitted to the zero order and Higuchi square root equations using 
GraphPad Prism 3.0 for comparative purposes. The rate constants derived from 
modeling studies were subjected to ANOVA at a significance level of α = 0.05, 
followed by post hoc tests, as described in section B12.1. The parameters obtained 
from curve-fitting were reported as mean values and the standard errors of the mean 
values were written in parentheses. The profiles of percent liquid uptake, swelling, 
hydrated area and matrix erosion were plotted against time and the standard errors of 







IV. RESULTS AND DISCUSSION 
PART 1. INFLUENCE OF ALGINATE PHYSICOCHEMICAL PROPERTIES 
ON MATRIX PERFORMANCE 
A. Effect of matrix tablet porosity 
The primary aim of determining the effect of matrix tablet porosity on drug release 
was to establish the range of matrix tablet porosity that did not influence drug release 
from alginate matrices. Matrix tablets containing 10 %, 30 % and 50 % Manucol LB 
were compressed at different pressures to produce tablets of porosities ranging from 
0.08 to 0.2. Attempts to produce matrix tablets with porosities below the 
abovementioned range resulted in tablet capping upon ejection from the die. Drug 
release studies showed that there was not much difference in the drug release profiles 
of tablets with the same alginate concentration but different porosities (Fig. 4; Table 
4). Hence, drug release was independent of the dry matrix porosity. A gel barrier 
formed around the matrix tablet when it was placed in the dissolution medium. The 
drug release rate was therefore expected to be more closely related to the porosity of 
the hydrated gel layer. 
 
B. Screening the influence of sodium alginate grade on matrix performance 
Different grades of alginate differ in their physicochemical properties, namely median 
particle size, solution viscosity and MG ratio (Table 5). Matrices of different grades 
and formulations showed differing drug release kinetics. However, most of the 
dissolution data obtained at pH 1.2 or pH 6.8 fitted Higuchi or zero order equations, 
respectively (Table 6). Hence dissolution data obtained at pH 1.2 and pH 6.8 were 
























Fig. 4. Effect of matrix tablet porosity, ε, on drug release from 10 % (white symbols), 
30 % (grey symbols) and 50 % (black symbols) Manucol LB matrices. ε = 0.08 (○); ε 
= 0.10 (□, ■, ■); ε = 0.15 (∆, ▲, ▲); ε = 0.20 (◊, ♦, ♦). 
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Out of 51 formulations, 19 had less than 4 dissolution data points for determination of 
drug release rate at pH 6.8 (Table 7). This was because most of the drug was released 
in the preceding acidic phase. Since the model-dependent approach is recommended 
when at least 4 or more dissolution data points are available (Sathe et al., 1996), 
model-independent dissolution parameters T25% and T75% were also used to 
characterize drug release (Fig. 5). 
 
 
Table 4. Effect of matrix porosity on drug release rate from alginate matrices 
Drug release rate Alginate 
concentration (%) 
Matrix porosity
pH 1.2 pH 6.8 































a Drug release rate (% min-0.5) was determined by curve-fitting to the Higuchi 
  equation. Drug release rate for other matrices was expressed as % min-1. 
b Significantly different compared to each other within the same alginate 
  concentration. 









Table 5. Physicochemical properties of sodium alginate 




M (%)c G (%)c MG 
ratiod 
      
Manucol LB 164.0 2.8 61 39 1.6 
Maucol LF 177.6 12.1 61 39 1.6 
Manucol DH 207.3 28.0 61 39 1.6 
Manucol LKX 32.9 50.8 61 39 1.6 
Manucol DMF 95.5 89.6 61 39 1.6 
Manucol SS/LL 214.2 108.2 61 39 1.6 
Keltone LVCR 77.0 21.3 60 40 1.5 
Keltone HVCR 59.0 153.8 60 40 1.5 
Kelvis 49.0 331.4 61 39 1.6 
Kelcosol 68.0 600.2 60 40 1.5 
Manugel LBA 155.5 2.5 37 63 0.6 
Manugel LBB 197.1 4.8 37 63 0.6 
Manugel GHB 223.7 30.4 37 63 0.6 
Manugel GMB 226.2 69.3 37 63 0.6 
Manugel DJX 48.9 90.2 37 63 0.6 
Manugel DMB 82.3 115.4 37 63 0.6 
Manugel DPB 228.5 241.7 37 63 0.6 
 
a Determined from laser diffractometry 
b Determined from viscometry using 1 % w/w alginate solution 
c According to Lawson, 2003 












   Table 6(A). Curve-fitting of dissolution data obtained at pH 1.2. 
 
 
Zero order equation  Higuchi equation Alginate content 
(%) 
Alginate grades 
SS Sy.x R²   SS Sy.x R² 
         
10 Manucol LB 232.3 3.049 0.9529  140.1 2.367 0.9716 
 Manucol LF 171.3 2.618 0.9732  143.1 2.392 0.9776 
 Manucol DH  478.4 4.374 0.9395  286.5 3.385 0.9637 
 Manucol LKX 259.9 3.224 0.9639  8.121 0.5699 0.9989 
 Manucol DMF 71.56 1.692 0.9882  71.08 1.686 0.9882 
 Manucol SS/LL 230.8 3.798 0.9572  8.665 0.7359 0.9984 
 Keltone LVCR 83.06 2.882 0.98  17.01 1.304 0.9959 
 Keltone HVCR 172.9 4.158 0.965  5.55 0.745 0.9989 
 Kelvis 154 3.924 0.9641  44.35 2.106 0.9896 
 Kelcosol 207.7 4.558 0.9715  68.11 2.61 0.9906 
 Manugel LBA 264.3 3.252 0.9663  33.06 1.15 0.9958 
 Manugel LBB 283.8 6.877 0.8808  274.7 6.767 0.8846 
 Manugel GHB 697.1 5.28 0.9159  355.7 3.772 0.9571 
 Manugel GMB 1399 7.48 0.8484  716.7 5.354 0.9223 
 Manugel DJX 94.26 1.942 0.9917  145 2.409 0.9872 
 Manugel DMB 115.9 2.153 0.9866  50.5 1.421 0.9942 
 Manugel DPB 1011 6.359 0.8731  564.8 4.753 0.9291 
         
30 Manucol LB 4.5 0.4243 0.9989  91.07 1.909 0.978 
 Manucol LF 48.51 2.203 0.9792  14.59 1.208 0.9937 
 Manucol DH  163.2 4.04 0.9344  77.28 2.78 0.969 
 Manucol LKX 73.85 2.718 0.967  1.322 0.3636 0.9994 
 Manucol DMF 56.84 2.015 0.9822  17.19 1.108 0.9946 
 Manucol SS/LL 91.18 3.02 0.9663  14 1.183 0.9948 
 Keltone LVCR 91.28 3.021 0.9744  15.56 1.247 0.9956 
 Keltone HVCR 155.5 3.943 0.9616  28.55 1.69 0.9929 
 Kelvis 81.48 2.854 0.9742  5.973 0.7729 0.9981 
 Kelcosol 97.87 3.128 0.9842  52.49 2.291 0.9915 
 Manugel LBA 80.28 2.056 0.9908  188.3 3.148 0.9784 
 Manugel LBB 891.5 6.366 0.9262  482.2 4.682 0.9601 
 Manugel GHB 110.9 3.33 0.9667  32.21 1.795 0.9903 
 Manugel GMB 415.2 6.444 0.8947  197 4.438 0.95 
 Manugel DJX 162 4.025 0.9759  52.22 2.285 0.9922 
 Manugel DMB 255.9 5.058 0.962  153.1 3.913 0.9773 
 Manugel DPB 152.4 3.904 0.9506  13.37 1.156 0.9957 
         
50 Manucol LB 61.95 1.678 0.9876  103.9 2.173 0.9793 
 Manucol LF 50.92 2.257 0.977  10.02 1.001 0.9955 
 Manucol DH  174.4 4.176 0.9307  19.08 1.381 0.9924 
 Manucol LKX 43.85 2.094 0.9778  7.096 0.8424 0.9964 
 Manucol DMF 104.8 3.238 0.9675  10.21 1.011 0.9968 
 Manucol SS/LL 118 3.436 0.9568  36.11 1.9 0.9868 
 Keltone LVCR 108.8 3.298 0.9742  68.58 2.619 0.9837 
 Keltone HVCR 134.9 3.673 0.9594  13.87 1.178 0.9958 
 Kelvis 45.92 2.143 0.9844  28.28 1.682 0.9904 
 Kelcosol 74.57 2.731 0.9848  40.02 2 0.9918 
 Manugel LBA 50.48 1.63 0.9955  322.2 4.118 0.971 
 Manugel LBB 21.37 1.462 0.9972  243.6 4.936 0.9686 
 Manugel GHB 69.21 2.631 0.9849  48.08 2.193 0.9895 
 Manugel GMB 141.2 3.758 0.9745  23.94 1.547 0.9957 
 Manugel DJX 123.1 3.509 0.9831  106.4 3.262 0.9854 
 Manugel DMB 212.9 4.614 0.9706  24.46 1.564 0.9966 
 Manugel DPB 108.4 3.292 0.9774  23.24 1.524 0.9951 
 





        Table 6(B). Curve-fitting of dissolution data obtained at pH 6.8. 
 
Zero order equation  Higuchi equation Alginate content  
(%) 
Alginate grades 
SS      Sy.x      R²  SS      Sy.x      R² 
         
10 Manucol LB a       
 Manucol LF 99.94 3.161 0.7969  101.3 3.183 0.7941 
 Manucol DH  a       
 Manucol LKX 22.74 1.508 0.9645  28.59 1.691 0.9554 
 Manucol DMF 61.06 2.471 0.9384  63.85 2.527 0.9356 
 Manucol SS/LL a       
 Keltone LVCR a       
 Keltone HVCR a       
 Kelvis a       
 Kelcosol a       
 Manugel LBA 41.17 2.029 0.9526  46.96 2.167 0.946 
 Manugel LBB a       
 Manugel GHB a       
 Manugel GMB a       
 Manugel DJX 5.333 0.5773 0.9941  7.004 0.6616 0.9922 
 Manugel DMB 19.04 1.091 0.9853  21.23 1.152 0.9836 
 Manugel DPB a       
         
30 Manucol LB 31.1 1.764 0.9874  41.96 2.048 0.983 
 Manucol LF 209.6 4.578 0.943  213.8 4.624 0.9418 
 Manucol DH  21.46 1.751 0.977  18.46 1.624 0.9802 
 Manucol LKX 34.41 1.855 0.977  46.04 2.146 0.9693 
 Manucol DMF 58.17 2.542 0.9528  63.59 2.658 0.9484 
 Manucol SS/LL 60.36 2.457 0.966  62.23 2.495 0.965 
 Keltone LVCR 99.01 3.147 0.946  99.61 3.156 0.9456 
 Keltone HVCR 51.74 2.275 0.9442  51.11 2.261 0.9448 
 Kelvis 20.86 1.267 0.9886  30.02 1.52 0.9836 
 Kelcosol a       
 Manugel LBA a       
 Manugel LBB a       
 Manugel GHB 116.4 3.412 0.9169  114.5 3.384 0.9182 
 Manugel GMB 300.2 5.479 0.7076  297.3 5.453 0.7105 
 Manugel DJX a       
 Manugel DMB 27.33 1.653 0.9707  30.87 1.757 0.9669 
 Manugel DPB 59.36 2.436 0.9209  54.72 2.339 0.9271 
         
50 Manucol LB 156.3 3.954 0.9086  167.4 4.091 0.9022 
 Manucol LF 204.3 4.52 0.927  198.5 4.455 0.929 
 Manucol DH  96.12 3.1 0.8984  98.56 3.139 0.8958 
 Manucol LKX 138.2 3.393 0.9362  113.7 3.078 0.9475 
 Manucol DMF 83.44 2.284 0.9632  82.41 2.269 0.9637 
 Manucol SS/LL 80.36 2.486 0.9464  64.28 2.224 0.9572 
 Keltone LVCR 37.35 1.933 0.9726  40.4 2.01 0.9704 
 Keltone HVCR 27.93 1.466 0.9814  29.62 1.509 0.9803 
 Kelvis 68.03 2.288 0.942  63.08 2.203 0.9462 
 Kelcosol 36.71 1.68 0.9644  15.92 1.107 0.9846 
 Manugel LBA a       
 Manugel LBB a       
 Manugel GHB 102.2 3.197 0.8931  95.08 3.083 0.9006 
 Manugel GMB a       
 Manugel DJX a       
 Manugel DMB 44.17 2.102 0.9087  49.67 2.229 0.8973 
 Manugel DPB 28.73 1.695 0.9607  18.7 1.367 0.9744 
 
SS: Sum of squares; Sy.x: Standard deviation of the residuals  
a Insufficient data points for curve-fitting (< 4 data points) 
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Table 7. Drug release rate at pH 1.2 and pH 6.8 for matrices containing 10, 30 or 50% 
alginate of different grades 
 
 
Drug release rate at pH 1.2 (% min-0.5) Drug release rate at pH 6.8 (% min-1) Alginate grade 
10 % 30 % 50 % 10 % 30 % 50 % 
       
Manucol LB 
Manucol LF 






















































































































a Better described by zero order model 
b Insufficient data points for curve-fitting (< 4 data points) 



































































Manucol LB Manucol LF Manucol DH
Manucol LKX Manucol SS/LL Manucol DMF



































































Manugel LBA Manugel LBB Manugel GHB
Manugel GMB Manugel DJX Manugel DMB
Manugel DPB
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B1. Influence of sodium alginate concentration 
In general, drug release rates at pH 1.2 decreased as alginate concentration increased 
from 10 % to 30 % (Table 7). Similarly, dissolution T25% and T75% values increased 
when alginate concentration was increased from 10 % to 30 % (Fig. 5). Faster drug 
release shown by 10 % alginate matrices could be attributed to the formation of a less 
effective diffusion barrier due to fewer polymer particles available for the formation 
of a continuous gel barrier. In contrast, higher polymer concentration gave rise to a 
more effective diffusion barrier to retard drug release. However, further increase in 
polymer concentration from 30 % to 50 % reduced drug release rates at pH 1.2 in only 
5 of 17 formulations while other formulations showed increased or minimal changes 
in drug release rates. Results obtained with dissolution parameters T25% or T75% 
echoed this trend but slower release with increase of alginate concentration from 30 % 
to 50 % was observed in half of the cases (Fig. 5). The effect of alginate concentration 
on drug release rates at pH 6.8 could only be evaluated in a few cases due to 
insufficient data points for curve-fitting (Table 7). Drug release rates at pH 6.8 mainly 
decreased with increase in alginate concentration from 30 % to 50 % (Table 7).  
 
Although increasing the polymer content in a matrix delivery system usually led to a 
reduction in drug release rate (Alderman, 1984; Rekhi et al., 1999; Gao et al., 1996), 
this was not always the case with the alginate matrix tablets in this study. Close 
examination of these tablets showed that the integrity of the matrices was adversely 
affected during the dissolution study. Varying patterns of deformation, depicted by 
the presence of surface cracks, grooves and lamination were observed (Fig. 6). The 
extent of deformation was greater at higher alginate concentrations. As polymer 
content increased, the extent of matrix swelling also increased due to greater liquid 
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imbibition (Wan et al., 1992 and 1993). The latter caused pressure built-up within the 
matrix which could be released by matrix deformation. In the acidic medium, the 
conversion of sodium alginate to insoluble alginic acid which could swell without 
generating surface stickiness could further contribute to the inability of the matrices to 
maintain their integrity. These effects might have compromised the gel barrier 
developing around the matrix and exposed greater surface area to the dissolution 
medium. Hence, the resultant drug release parameters were affected by these 
compounding factors. The lack of association between alginate concentration and 
drug release rate was observed particularly for the high-G alginate matrices. These 
matrices were particularly prone to crack formation. The development of cracks or 
lamination could have contributed to the increase in drug release rates at pH 1.2 as 
alginate concentration was increased from 30 % to 50 % (Table 7). 
                                
 
Fig. 6. Morphology of 50 % alginate matrix after dissolution at pH 1.2 for 2 h. (A) 
Manucol LB and Manugel LBA; (B) Manucol DH and Manugel GHB; (C) Manucol 






Manucol                  Manugel 
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B2. Influence of sodium alginate particle size and viscosity 
The degree of association between sodium alginate particle size or viscosity and drug 
release parameters was determined using correlation analysis. Drug release 
parameters used were T25%, T75%, drug release rates at pH 1.2 and pH 6.8 as well as 
Y-axis intercept which represents a lag or burst in drug release. Tables 8 (A) and (B) 
show the Pearson correlation coefficient between the dissolution parameters used and 
the polymer variables investigated.  
 
Correlation analysis for all 17 grades of sodium alginate showed that only particle 
size could be correlated well with dissolution parameters T25%, T75% and the Y-axis 
intercept derived from the Higuchi equation at 10 % and 30 % sodium alginate 
concentration. The relationship among these variables was further investigated using 
surface plots (Fig. 7 and 8). The surface plots of 10 % alginate matrices showed that 
drug release was strongly associated with alginate particle size. In general, as the 
particle size decreased, T25% and T75% increased. The Y-axis intercept values showed 
the opposite trend (Fig. 8). A plateau for T25% and T75% was observed as particle size 
decreased further. The particle size value beyond which T25% or T75% leveled-off was 
around 100 µm. Surprisingly, a correlation between drug release rates at pH 1.2 and 
particle size of sodium alginate was not observed (Table 8). Correlation between 
alginate median particle size and the Y-axis intercept values suggests that alginate 
particle size affected the initial lag or burst in drug release at 10 % and 30 % alginate 
concentrations. Dissolution parameters T25% and T75% were influenced by the initial 
lag or burst release. T25% and T75% values were significantly correlated with the Y-axis 
intercept values at 10 % alginate (P < 0.05). These results showed that particle size 
played a crucial role during the initial stages of diffusion barrier formation.  
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Table 8. Correlation between drug release parameters and (A) alginate median particle 
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a Correlation is significant at the 0.05 level (2-tailed) 
b Outlier (Kelcosol) was removed from correlation analysis (Refer to Appendix 2) 
c Insufficient data points for analysis (less than 4 samples) 
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Fig. 8. Surface plots for Y-intercept values at (A) 10 % and (B) 30 % alginate. 
 











Smaller particles led to rapid formation of the diffusion barrier resulting in a slight lag 
prior to drug release (negative values of the Y-intercept) while larger particles gave 
rise to initial burst release (positive values of Y-intercept). The rate of drug release 
occurring after the barrier had formed was thus independent of the initial polymer 
particle size.  
 
Alderman (1984) reported that smaller particles hydrated faster, leading to quicker gel 
barrier formation and hence slower drug release. Contrary to Alderman’s theory, 
Mitchell et al. (1993) reported that larger HPMC particles showed higher initial 
hydration rates compared to smaller particles. Thus, it was postulated that the higher 
release rates observed for matrices with larger HPMC particles was due to the relative 
lack of polymer particles and not the particle size per se. For the same amount of 
alginate, a reduction in particle size is accompanied by an increase in the number of 
particles and an enhancement in the polymer surface area (Fig. 9).  Hence, the use of 
smaller alginate particles would favor interparticulate contact, contributing to better 
polymer particle coalescence which gave rise to a less permeable diffusion barrier for 








Fig. 9. Illustration of particle size effect on diffusion barrier formation at low polymer 









Swollen alginate particle 
Dry alginate particle 
Greater interparticulate contact 
allowed formation of polymer 
network 
Isolated swelling particles 
did not favor polymer 
network formation 
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It was interesting to note that the dissolution parameters were more sensitive to a 
change in alginate concentration when alginate particles were larger. Fig. 10 shows 
that the effect of alginate concentration on drug release (T25% and Y-intercept values) 
was most noticeable for matrices containing larger sodium alginate particles when 
alginate content was increased from 10 % to 30 %. The increase in T25% and T75% 
values when alginate content was increased from 10 % to 30 % was more than 100 % 
for alginates with median particle sizes of about 200 µm and above [Manugels (LBB, 
GHB, GMB and DPB) and Manucols (DH and SS/LL)]. Most of these alginate 
matrices showed 81 to 113 % decrease in burst release with increase of polymer 
content from 10 % to 30 %. On the contrary, increasing the concentration of alginates 
with smaller particle sizes from 10 % to 30 % did not augment T25% and T75% to that 
extent. The relative lack of alginate particles when larger particles were used resulted 
in areas on the tablet surface where there was an absence of polymer as noted by 
Mitchell et al. (1993) while working with HPMC matrices. Dissolution medium 
would enter through these areas and cause a burst release of drug before a protective 
barrier could be formed. Increasing polymer concentration would provide more 
particles to cover the tablet surface and reduce the polymer-free areas. With smaller 
particles, a sufficiently complete diffusion barrier was formed before significant burst 
release could occur, even at 10 % alginate content. The extent of increase in surface 
coverage would be greater for larger particles than for smaller ones with the addition 
of more polymer, leading to a greater enhancement in drug retardation observed with 







































Fig. 10. Contour plots showing the influence of alginate median particle size on the 
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At 30 % and 50 % sodium alginate levels, the influence of particle size was not as 
apparent. With 10 % alginate concentration, the extent of tablet surface coverage by 
alginate particles depended largely on the relative number of alginate particles present 
in the system. For the same amount of alginate, smaller particles would translate into 
relatively greater number of particles per unit weight, and hence, greater extent of 
tablet surface coverage. It follows that the porosity of the gel barrier formed would 
depend mainly on the relative number of alginate particles on the tablet surface. 
Therefore, at low alginate concentration, drug release was sensitive to particle size 
effect because at this concentration, the porosity of the gel barrier was highly 
dependent on the relative abundance of particles available on the tablet surface. At 
higher alginate concentration, there were adequate particles to form a stable gel 
barrier. Hence, drug release from these matrices was modulated by factors other than 
particle size. These factors include differences in liquid uptake, swelling, as well as 
matrix deformation during dissolution as observed for alginate matrices in this study. 
The masking of particle size effect by the concentration effect at higher alginate 
content was in agreement with other research findings carried out with HPMC 
(Mitchell et al., 1993; Velasco et al., 1999; Heng et al., 2001).  
 
When the alginates were grouped according to their composition as either high-M or 
high-G alginates, similar results as those described for all 17 grades were obtained 
(Table 8). This showed that the influence of particle size on drug release was not 




On the other hand, the influence of alginate viscosity was not apparent from the 
surface plots (Fig. 7 and 8) and correlation analysis did not indicate clear association 
between dissolution parameters T25%, T75% or Y-intercept and alginate viscosity. 
However, a correlation was found between drug release rates at pH 6.8 and alginate 
viscosity at 10 % alginate concentration (Table 8). No such correlation was found at 
pH 1.2. This suggests that the influence of alginate viscosity was only manifested at 
near-neutral pH, where sodium alginate existed in its soluble form. At pH 1.2, sodium 
alginate was converted to insoluble alginic acid and was not able to exert its viscosity 
effect. Further investigations were subsequently carried out to ascertain the influence 
of viscosity. Dissolution parameters T25% and T75% were affected by the initial release 
phase, which was dependent on particle size as well as alginate concentration. Hence, 
the influence of viscosity was masked by that of particle size and alginate 
concentration when T25% and T75% were used for analysis. 
 
B3. Influence of mannuronic and guluronic acid ratio in sodium alginate 
Grades of sodium alginate with different MG ratio but similar median particle sizes 
and viscosities were compared to determine the effect of MG ratio on drug release 
rates (Table 9). In general, M-rich alginates (Manucols) gave lower drug release rates 
at pH 1.2 while G-rich alginates (Manugels) gave lower drug release rates at pH 6.8.  
 
As the pKa of M residues is lower than that of G residues (Haug, 1964), alginates with 
higher M content require lower pH to precipitate (Haug and Larsen, 1963). Haug et al. 
(1967) reported that M-rich alginate fragments are more soluble in acid than G-rich 
alginate fragments. The higher solubility of M-rich fragments at acidic pH suggests 
that M-rich alginates are able to hydrate and build-up the diffusion barrier faster than 
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G-rich alginates. Examination of alginate matrices during dissolution at pH 1.2 
revealed contrasting morphologies (Fig. 6). Matrices consisting of high-G alginates 
showed multiple crack formation (which will be described as “lamination” in this 
thesis) while high-M matrices showed less extensive crack development or no visible 
signs of cracks. The gradual development of cracks compromised the function of the 
diffusion barrier and resulted in higher rates of drug release from high-G matrices at 
acidic pH. However, the Y-intercept values for G-rich alginates were lower (Table 9). 
This suggests that crack development only occurred after the formation of an intact 
diffusion barrier and did not affect the initial amount of drug released. 
 
On the other hand, G-rich alginates slowed down drug release more than the M-rich 
alginates in the buffer phase. The observation in the buffer phase is in agreement with 
the findings of other studies that employed pH 7.2 buffer systems for dissolution tests 
(Veski and Marvola, 1993; Sirkiä et al., 1994). At near-neutral pH, G-rich alginates 
formed more rigid gels upon hydration compared to M-rich alginates (Veski and 
Marvola, 1993). The former is less prone to erosion and thus constitutes a more 
effective barrier to drug release. However, when alginate matrices were subjected to 






Table 9. Influence of MG ratio on drug release from 10, 30 or 50 % alginate matrices at (A) pH 1.2 and (B) pH 6.8. 
(A) 
Drug release parameter at pH 1.2 a 
10 % alginate 30 % alginate 50 % alginate 





Particle  size 
(µm) Rate Y-intercept Rate Y-intercept Rate Y-intercept 
Manucol LB 1.6 2.8 164 4.95 (0.17)b 2.23 (1.11)b 4.55 (0.14)b -5.66 (0.89)b 5.03 (0.16)b -9.06 (1.02)b 
Manugel LBA 0.6 2.5 155 6.32 (0.08)b -3.00 (0.54)b 7.69 (0.25)b -14.86 (1.66)b 8.64 (0.34)b -20.08 (2.17)b 
Manucol DH 1.6 28.0 207 6.24 (0.24) 13.01 (1.58) 4.68 (0.27)b 0.93 (1.90) 4.76 (0.13)b 5.78 (0.94)b 
Manugel GHB 0.6 30.4 224 6.37 (0.27) 11.04 (1.76) 5.48 (0.17)b -1.39 (1.23) 6.42 (0.21)b -9.17 (1.50)b 
Manucol DMF 1.6 89.6 96 5.53 (0.12)b -5.81 (0.79) 4.73 (0.09)b -5.90 (0.67)b 5.41 (0.10)b -8.00 (0.69)b 
Manugel DMB 0.6 115.4 82 6.63 (0.10)b -7.23 (0.66) 7.74 (0.37)b -11.33 (2.67)b 8.10 (0.15)b -13.80 (1.07)b 
 
(B) 





Particle size (µm) 10 % alginate 30 % alginate 50 % alginate
Manucol LB 1.6 2.8 164  c  0.35 (0.01)  0.28 (0.03)
Manugel LBA 0.6 2.5 155  0.50 (0.04)  c  c 
Manucol DH 1.6 28.0 207 0.27 (0.05)b  0.21 (0.01)b  0.11 (0.02)
Manugel GHB 0.6 30.4 224 0.21 (0.03)b  0.15 (0.02)b  0.14 (0.02)
Manucol DMF 1.6 89.6 96  0.22 (0.02)b  0.16 (0.01)  0.11 (0.01)
Manugel DMB 0.6 115.4 82  0.14 (0.00)b  0.13 (0.01)  0.08 (0.02)
 
a Drug release rates at pH 1.2 and pH 6.8 are expressed as % min-0.5 and % min-1, respectively. 
b Difference was statistically significant (P < 0.05). 
c Release rates were not calculated due to insufficient data points. 
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C. Investigation on the effect of alginate viscosity using two viscosity grades of 
alginate 
The influence of alginate viscosity on drug release was not conclusively demonstrated 
in the screening study using 17 grades of alginate. A significant relationship between 
alginate viscosity and drug release rate was only noted at 10 % alginate at pH 6.8 
(Table 8). Sodium alginate becomes insoluble at acidic pH and a more critical 
investigation of this factor is warranted. Further investigation on alginate viscosity 
effect was carried out using two M-rich alginate grades, Manucol LB and Manucol 
SS/LL, with kinematic viscosities of 2.8 mm2 s-1 and 108.2 mm2 s-1, respectively. 
These alginates were sieved to obtain similar size fractions and the release profiles of 
matrix tablets at 10 %, 30 % and 50 % alginate content were determined.   
 
Alginate viscosity influenced drug release in a contrasting manner depending on the 
dissolution media pH (Fig. 11). At pH 1.2, drug release was slower from matrices 
containing lower viscosity alginate, compared to matrices of higher viscosity alginate 
(Table 10). At pH 6.8, drug release became faster for low-viscosity alginate matrices 
relative to high-viscosity alginate matrices and this pattern was observed at all 3 
alginate concentrations. The faster drug release from a high-viscosity alginate matrix 
in the acidic phase is somewhat surprising since many have reported that polymers 
with higher viscosities retarded drug release to a greater extent than lower-viscosity 
polymers (Alderman, 1984; Wan et al., 1992; Campos-Aldrete and Villafuerte-
Robles, 1997). However, these cited studies employed pH-insensitive hypromellose 
matrices which formed viscous gel barriers when hydrated. At pH 1.2, sodium 
alginate is converted to insoluble alginic acid. It was proposed that the alginic acid 


























Fig. 11. Drug release profiles from matrices containing sieved fractions of 180-250 
μm (○, ●) or 90-125 μm (□, ■) of Manucol SS/LL (open symbol) or Manucol LB 





















































Table 10. Influence of alginate viscosity on drug release at (A) pH 1.2 and (B) pH 6.8 




Release rate at pH 1.2 (% min-0.5) Y-intercept (%) Alginate 
content (%) 
Size fraction 
(μm) Manucol SS/LL Manucol LB Manucol SS/LL Manucol LB 
180-250 6.12 (0.12) 4.86 (0.28)c 26.63 (0.81) 24.16 (1.81) 10 
90-125 6.37 (0.08) 5.08 (0.11)c 3.50 (0.52) 1.31 (0.70) 
180-250 5.06 (0.13) 3.68 (0.03)c 13.80 (0.85) 6.11 (0.22)c 30 
90-125 4.48 (0.06) a -0.23 (0.36) a 
180-250 4.79 (0.10) 4.53 (0.14)c 14.16 (0.69) 5.11 (0.94)c 50 





Release rate at pH 6.8 (% min-1) Alginate 
content (%) 
Size fraction 
(μm) Manucol SS/LL Manucol LB 
180-250 b b 10 
90-125 b b 
180-250 0.16 (0.01) 0.55 (0.02)c 30 
90-125 0.17 (0.00) 0.38 (0.02)c 
180-250 0.13 (0.00) 0.25 (0.01)c 50 
90-125 0.13 (0.00) 0.33 (0.02)c 
 
 
a Drug release followed zero order kinetics.  
b Insufficient data points for curve-fitting. 













a dilute gel which facilitated bonding of neighboring alginate particles (Hodsdon et 
al., 1995). Since initial hydration of the polymer is essential for the development of an 
intact barrier, the rate of hydration will determine how rapid the barrier forms. Higher 
alginate viscosity could have reduced the rate of alginate particle hydration in the 
acidic phase. The lag in barrier formation was reflected by the higher extent of burst 
release shown by Manucol SS/LL matrices (Table 10). Reduced rate of barrier 
formation allowed greater amount of liquid to imbibe into Manucol SS/LL matrices, 
resulting in higher apparent matrix swelling. Upon immersion in acidic media, 
Manucol SS/LL matrices swelled and formed porous and friable outer layer that was 
easily eroded. Higher rates of drug release from Manucol SS/LL matrices suggests 
that the alginic acid barrier formed from higher viscosity alginate was less effective in 
retarding drug release, probably due to higher barrier porosity as a result of reduced 
formation of the dilute, viscous alginate gel during the initial stages of hydration. At 
pH 6.8, alginic acid was re-converted to the soluble sodium alginate, giving rise to a 
viscous gel barrier. The higher viscosity alginate grade, Manucol SS/LL, formed a 
more viscous and erosion-resistant gel barrier which retarded drug release more 
effectively (Table 10).  
 
Besides showing the influence of alginate viscosity, Fig. 11 also illustrates the 
influence of alginate particle size fraction on drug release from alginate matrices. This 
will be further explored in the following section. At all 3 alginate concentrations, drug 
release from Manucol SS/LL matrices followed the Higuchi model at pH 1.2 and zero 
order model at pH 6.8. On the other hand, drug release model for Manucol LB 
matrices was found to depend on particle size and alginate concentration used. This 
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suggests that drug release mechanism from matrices containing alginates with 
relatively low viscosity was more sensitive to particle size and alginate content.  
 
D. Investigation of particle size effect using Manucol LB 
D1. Investigation using sieved fractions of sodium alginate 
Screening study has shown that initial drug release from sodium alginate matrices was 
influenced by the median particle size of alginate. However, the effect of particle size 
alone could not be clearly ascertained since the various grades of alginate also 
differed in their viscosity and composition. In addition, preceding studies on the 
influence of alginate viscosity also demonstrated the impact of alginate particle size 
on drug release (Table 10). Hence, further investigation into particle size effect was 
carried out using a particular grade of sodium alginate (Manucol LB).  
 
Manucol LB was sieved into fractions of 180-250 µm, 125-180 µm, 90-125 µm and < 
90 µm and each size fraction was incorporated into matrix tablets at 5 % and 10 % 
alginate concentration. The release profiles of these tablets were subsequently 
determined. A reduction in drug release rate with a decrease in particle size fraction 
was only observed at 5 % alginate concentration (Table 11). The effect of particle size 
on the Y-intercept values was clearly observed at 10 % alginate. This was in 
agreement with findings from the screening study. At 5 % alginate, only the smallest 
size fraction showed a significant difference in the Y-intercept values, mainly due to 
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a Dissolution data was curve-fitted to the Higuchi model for comparative purposes 
b Y-intercept of Higuchi model 
c Better described by zero order model 
Refer to Appendix 3 for statistical analysis. 
 
 
Positive Y-intercept value represents burst release from alginate matrix tablets. Burst 
release is often observed prior to or during the development of a diffusion barrier 
capable of controlling the penetration of dissolution medium and drug diffusion 
(Huang and Brazel, 2001). Once the diffusion barrier formed, drug release slowed 
down and this was reflected by a change in the slope of the dissolution profiles. 
During the initial phase of drug release, surface erosion from the matrix was 
observed. This suggests that the alginate particles were not yet sufficiently hydrated to 
coalesce with neighboring particles to form a continuous barrier. Surface erosion was 
further aggravated by the relative scarcity of alginate particles to bind with 
neighboring particles upon hydration, particularly when larger alginate particles were 
 76
used. The faster release rate observed with 5 % matrices containing the two larger size 
fractions could also be due to the disintegrating action of isolated alginic acid 
particles.   
 
The change in pH from 1.2 to 6.8 resulted in a change in the gel barrier properties due 
the re-conversion of alginic acid to sodium alginate. This conversion produced an 
apparent change in the release profile as well as a morphological transformation of the 
matrices. The rough and porous outer layer slowly became smooth and viscous 
following pH-change and drug release became faster as the matrices gradually eroded. 
The matrices completely dissolved at the end of the dissolution process. Being 
insoluble, the alginic acid barrier was more resistant to erosion compared to the 
soluble sodium alginate barrier. The higher rate of erosion explains the faster release 
in the pH 6.8 buffer media. The data points collected after pH-change could not be 
curve-fitted due to lack of data points as drug release was almost complete at pH 1.2 
(5 % alginate matrices) or was too rapid to allow sufficient data points to be collected 
(10 % alginate matrices). 
 
Other investigations have shown that particle size effect is masked at higher polymer 
concentration (Mitchell et al., 1993; Campos-Aldrete and Villafuerte-Robles, 1997; 
Velasco et al., 1999; Heng et al., 2001). Nevertheless, matrices containing 30 % and 
50 % Manucol LB were made using size fractions of 180-250 µm and 90-125 µm to 
examine whether particle size effect could still be observed at higher alginate 
concentration. Both alginate size fractions gave rise to different models of drug 
release. The larger and smaller size fractions resulted in Higuchi or zero order release 
kinetics, respectively, at pH 1.2 (Table 11). The zero order rates were 0.32 (0.01) and 
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0.36 (0.01) % min-1, for matrices with 30 % or 50 % alginate of 90-125 μm size 
fraction, respectively. At pH 6.8, dissolution profiles followed zero order kinetics, 
suggesting that drug diffusion occurred through a gel layer of constant thickness with 
respect to time. This was attributed to the synchronization of alginate swelling and 
alginate gel layer erosion rates. Dissolution profiles of matrices containing alginate 
size fraction of 90-125 µm at 30 and 50 % alginate concentration did not show any 
apparent phase transition and dissolution followed zero order kinetics for the entire 
dissolution profile (up to 90 % drug release). 
  
D2. Investigation on the homogeneity of alginate sieved fractions 
Blending of alginates with different viscosity is commonly employed to produce a 
product with the required viscosity (Draget, 2000). With this in mind, the viscosities 
of the sieved fractions were determined using 1 % w/w alginate solutions. It was 
found that the sieved fractions had significantly different viscosities (Table 12) and 
the viscosity values decreased as the particle size fraction decreased. This implied that 
the alginate sieved fractions were not homogeneous in terms of molecular weight 
distribution and probably chemical composition as well. In order to eliminate the 
possible confounding effects due to differences in molecular weights or chemical 
composition, and to investigate whether alginates having particles smaller than the 
smallest sieved fraction would further retard drug release, comminution of sodium 
alginate was carried out to produce milled fractions of different particle sizes and yet 




















D3. Comminution of sodium alginate 
In preliminary milling investigations, Manucol LB was milled using several mills: pin 
mill (24-pin, Retsch ZM 1000, Germany), centrifugal ball mill (Retsch, Germany) and 
hammer mill (AFG100, Hosokawa, Germany). Attempts to comminute sodium 
alginate using these mills at ambient temperature were unsuccessful. The highly 
plastic nature of sodium alginate presented considerable resistance to fracture. 
Furthermore, alginate is heat-sensitive and can degrade when milled using 
conventional mills which are usually associated with considerable heat generation.  
The alternative comminution method considered was the use of cryogenic milling 
where material temperature was reduced to sub-zero levels to increase its brittle 
behavior and to provide a temperature-controlled environment for size reduction.  
 
Manucol LB was cryogenically milled at 4 different speeds, 7500, 10000, 12500 and 
15000 rpm and alginate batches with median sizes of 88, 60, 44 and 41 µm were 
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produced, respectively. The extent of particle size reduction increased linearly with 
milling speed up to 12500 rpm, beyond which the particle size leveled off. This was 
because as particles became smaller, they were more difficult to mill since fewer 
flaws were present in the finer particles for crack propagation, which led to particle 
fracture. 
 
Viscosity measurements carried out on the 1 % w/w solutions of the milled alginate 
showed that the viscosity was not significantly different among the batches and the 
unmilled alginate (Table 12), implying that the batches were homogeneous in terms of 
molecular weight and chemical composition. The lack of change in solution viscosity 
also suggested that cryogenic milling did not contribute to alginate polymer 
degradation. 
 
The milled batches were subsequently incorporated into matrix tablets and dissolution 
studies carried out. Milled alginate batches of different median particle sizes did not 
affect the rate of drug release at each alginate concentration at pH 1.2 (P > 0.05) 
(Table 13). Compared to sieved alginate fraction of < 90 µm, milled alginate showed 
only slight differences in drug release rates (Table 11; Table 13). This suggests that 
the particle size threshold had been reached, below which there will be no apparent 
differences in drug release. This critical threshold value falls around 80-90 µm (Table 
12). This value agrees closely with the threshold value of about 100 µm obtained from 






Table 13. Effect of milled alginate on drug release rate at pH 1.2 




























































Drug release rate a and Y-intercept b obtained from curve-fitting to Higuchi equation. 











PART 2. MECHANISTIC INVESTIGATION ON THE IMPACT OF 
VISCOSITY AND MG RATIO ON THE HYDRATION BEHAVIOR OF 
ALGINATE MATRICES 
It was proposed that alginate viscosity affected the development of the diffusion 
barrier at acidic pH by determining the rate of polymer hydration. On the other hand, 
alginate MG ratio appeared to influence the integrity of the alginic acid barrier during 
dissolution. Matrices consisting of high-G alginates showed more extensive crack 
formation and faster drug release at acidic pH. Hence, the impact of alginate viscosity 
and MG ratio on alginate matrix hydration under simulated gastrointestinal pH 
conditions was determined. Matrix tablets without diluent were employed in this 
study to eliminate the influence of lactose. Viscosity effect was investigated using 
Manucol LB and Manucol SS/LL while the impact of MG ratio was studied by 
comparing Manucol SS/LL (high M) and Manugel DMB (high G) matrices. Manugel 
DMB matrices laminated during dissolution in acidic media. Liquid uptake, solvent 
front movement, swelling and erosion kinetics were studied to elucidate the 
mechanisms of diffusion barrier development and drug release from these matrices.  
 
A. Hydration behavior of alginate matrices 
The hydration behavior of alginate matrices was characterized by gravimetric and 
image analyses. 
 
A1. Gravimetric liquid uptake and matrix erosion 
The profiles of % weight change of the matrices showed the relative contributions of 
liquid uptake and matrix erosion (Fig. 12). At pH 1.2 (corresponding to dissolution 



































Fig. 12. Profiles of % weight change (dotted lines) and % liquid uptake per unit 
weight matrix remaining (solid lines) for Manucol SS/LL (○, ●) and Manucol LB (□, 






showed similar profiles but was greater for Manugel DMB matrices. Following pH 
change, an increase in % weight change was recorded for Manucol SS/LL and 
Manugel DMB matrices, with the later showing a decline in weight after 3 h of 
dissolution. Manucol LB matrices decreased in weight upon pH change as well. These 
observations corresponded with matrix erosion results (Fig. 13), which showed rapid 
erosion of Manucol LB and Manugel DMB matrices at pH 6.8.  
 
The rate and extent of liquid uptake are indicative of the polymer hydration process.  
Comparison between Manucol LB and Manucol SS/LL showed that alginate viscosity 
did not affect the rate of liquid uptake (P > 0.05). However, the initial uptake, 
represented by the Y-intercept values, was significantly higher for Manucol LB 
matrices compared to Manucol SS/LL matrices (Table 14). This suggests that lower 
viscosity alginate hydrated faster at acidic conditions, allowing quick build-up of the 
diffusion barrier. At pH 6.8, Manucol LB matrices showed exponential increase in 
liquid uptake (note that the last point was near complete erosion) while liquid uptake 
for Manucol SS/LL increased linearly. Manugel DMB matrices showed the highest 
liquid uptake at both pH 1.2 and pH 6.8. This was due to extensive lamination of 
these matrices which compromised the function of the diffusion barrier.  
 
The extent of liquid uptake was much greater at pH 6.8 relative to pH 1.2 for all 
matrices. At pH 6.8, alginic acid was re-converted to anionic sodium alginate. High 
ion concentration within the matrix due to de-protonation of acidic groups and 
diffusion of counterions from the surrounding medium enhanced liquid imbibition 
into the matrix via osmosis, resulting in increased swelling (Fig. 14) described by the 




























Fig. 13. Extent of matrix erosion of Manucol SS/LL (●), Manucol LB (■) and 






is characterized by an unequal distribution of diffusible ions between two ionic 
solutions (or gels) separated by a membrane or other kinds of restraint, such as 
gelation, which is impermeable to at least one of the ionic species present (IUPAC, 
1997). At pH 6.8, the ionized alginate formed part of the gel framework. Hence, it 
was considered non-diffusible. The unequal ionic distribution across the diffusion 
barrier resulted in higher osmotic pressure within the gelled matrix. This osmotic 
gradient drove solvent influx, resulting in matrix swelling. Liquid uptake in buffer 
occurred linearly for all matrices and only up to 5 h for Manucol LB matrices (the last 
time point was ignored due to near-complete matrix dissolution).  
 
Table 14. Summary of drug release and hydration kinetics of alginate matrices at pH  
1.2 and pH 6.8. 
 
pH 1.2 pH 6.8 Parameter (%) Alginate Grade 
Rate (%min-0.5) Y-Intercept (%) Rate (% min-1)
     
Drug release Manucol LB 2.58 (0.04) -2.31 (0.23) 0.33 (0.01) 
 Manucol SS/LL 3.23 (0.06) -1.87 (0.46) 0.11 (0.00) 
 Manugel DMB 6.57 (0.28)a -13.07 (1.99)a 0.13 (0.01)b 
     
Liquid uptake Manucol LB 8.79 (0.63) 28.04 (5.09) 2.33 (0.24) 
 Manucol SS/LL 9.14 (0.45) 13.39 (3.52) 1.80 (0.08) 
 Manugel DMB 18.35 (1.05) 18.20 (7.78) 4.44 (0.38) 
     
Matrix erosion Manucol LB 1.26 (0.06) 6.77 (0.48) 0.41 (0.03) 
 Manucol SS/LL 1.40 (0.14) -0.42 (1.07) 0.14 (0.01) 
 Manugel DMB 1.75 (0.13) 4.12 (1.00) 0.29 (0.01) 
     
Axial swelling Manucol LB 6.42 (0.39) 11.83 (2.96) 0.29 (0.10) 
 Manucol SS/LL 5.64 (0.27) 2.62 (2.02) 0.49 (0.05) 
 Manugel DMB 18.80 (1.03) -25.85 (8.25)  
     
Hydrated area Manucol LB 6.23 (0.27) 11.62 (2.05)  
 Manucol SS/LL 6.84 (0.59) -5.73 (4.84)  
 Manugel DMB 6.00 (0.27) 24.65 (2.12)  
 
a Better described by zero order model 

























Fig. 14. Axial (solid lines) and radial (dotted lines) swelling (relative to initial matrix 











Matrix erosion was less than 22 % in the acidic phase (less than 15 % if corrected for 
drug loss) and increased with time at pH 6.8 (Fig. 13). At low pH, the alginic acid 
barrier is relatively resistant to erosion as it is insoluble. At pH 6.8, alginate becomes 
soluble and more susceptible to erosion, the extent of which depends on the molecular 
weight of the polymer. Longer polymer chains form stronger polymer networks due to 
greater extent of polymer entanglement. As the gel layer becomes more dilute, and the 
‘disentanglement concentration’ is reached, the polymer chains forming the matrix 
disentangle and diffuse into the surrounding medium. The disentanglement 
concentration has been shown to decrease as the molecular weight of a polymer 
increases (Kavanagh and Corrigan, 2004). This suggests that polymers with higher 
molecular weight (Manucol SS/LL and Manugel DMB) had to hydrate more 
extensively to bring about greater dilution of the gel barrier before their polymer 
chains disentangled. Figures 12 and 13 show that Manucol SS/LL, Manugel DMB and 
Manucol LB matrices hydrated 600 %, 540 % and 188 %, respectively to produce ~ 
40 % matrix erosion. Hence, Manucol LB matrices eroded faster than Manucol SS/LL 
matrices since the later had to absorb more dissolution media before its gel barrier 
was sufficiently dilute for the polymer chains to disentangle. Even though Manucol 
SS/LL and Manugel DMB have similar viscosity values (Table 5), Manugel DMB 
matrices eroded faster due to quicker polymer hydration brought about by larger 
exposed surface area due to extensive matrix lamination. Percentage liquid uptake of 
540 % for Manugel DMB was achieved at 3.2 h while 5.5 h was required to achieve 





A2. Image analysis of matrix swelling and solvent penetration front 
A2.1 Matrix swelling 
Matrix swelling was anisotropic, with preferential swelling in the axial direction (Fig. 
14). Manucol LB matrices showed higher extent of axial swelling in the acidic phase 
relative to Manucol SS/LL matrices and this corresponded to the higher extent of 
liquid uptake per unit weight matrix remaining for the former. Radial swelling for 
Manucol LB and Manucol SS/LL matrices were similar and remained approximately 
constant in the acidic phase. Manugel DMB showed higher apparent swelling in both 
axial and radial directions due to greater amounts of liquid imbibed brought about by 
matrix lamination. Upon pH increase, Manucol SS/LL matrices continued to swell 
further in both axial and radial directions due to enhanced liquid uptake coupled with 
low erosion rates. Enhanced polymer relaxation in the pH 6.8 buffer phase relative to 
the acid phase was also attributed to the interaction and repulsion of charges along the 
anionic polymer chain (Brondsted and Kopecek, 1992). In contrast, Manucol LB 
matrices showed slower axial growth in the buffer phase without much change in 
radial dimensions up to approximately 4 h, after which, an intact core was no longer 
present due to extensive matrix dissolution. Measurements for Manugel DMB 
matrices were discontinued after 3 h as the matrices were too deformed. Wan et al. 
(1995) explained that the greater swelling seen with matrices containing higher 
molecular weight polymers was due to the larger hydrodynamic volume occupied by 
higher molecular weight chains when hydrated. The extent of matrix swelling was 
also a balance of liquid uptake and matrix erosion, as shown in this study. Aspect 
ratio was plotted against time to show the relative contributions of axial and radial 
swelling on overall matrix dimension (Fig. 15). In general, aspect ratio decreased with 























Fig. 15. Change in aspect ratio of Manucol SS/LL (●), Manucol LB (□) and Manugel 









Preferential axial swelling was attributed to the relief of stresses induced during 
compaction (Papadimitriou et al., 1993). It was also suggested that the particles, 
which were roughly globular in shape, had a tendency to regain spherical symmetry 
during hydration of the matrices (Malveau et al., 2002). Given that the surface area of 
both axial surfaces was greater than that of the radial surface (Table 15), more solvent 
was expected to penetrate from the axial surfaces, potentially causing higher extent of 
swelling in the axial direction. This postulation was tested by comparing the swelling 
behavior of matrices of different initial thickness made to similar porosities (Table 15) 
in acidic medium. Hydration at pH 1.2 was carried out for 18 h to ensure complete 
hydration of both types of matrices. Both types of matrices were found to exhibit 
preferential axial swelling and similar extent of radial swelling despite differences in 
initial axial and radial surface areas. If surface area had an influence on the extent of 
directional swelling, the larger radial surface area relative to the axial surface area of 
the thicker tablets would have resulted in greater radial swelling. The fact that axial 
swelling was still greater than radial swelling in both thick and thin matrices 
suggested that hydrating compacts had a propensity for preferential axial expansion in 
the direction opposite to the compression force.  
 












Matrix swelling at 
18 h (%) 
    Axial Radial Axial Radial 
Thin 3.7 10.0 2.7 149.4 111.8 116.4 22.6 





A2.2 Solvent penetration front 
Matrix cross-sections revealed gradual solvent ingress indicated by a distinct dye 
front (Fig. 16), which reached the core at around 3 h. Hence, this part of the study 
only focused on results obtained in the acidic phase (0 – 2 h). The extent of matrix 
hydration was represented by the % hydrated area (indicated by the stained region in 
Fig. 16), calculated relative to the entire cross-sectional area at each time point (Fig. 
17). Manugel DMB matrices showed the highest extent of hydration due to 
compromised barrier function. The extent of hydration of Manucol LB matrices 
relative to Manucol SS/LL matrices was greater but the rate of matrix hydration did 
not show significant differences (P > 0.05). This was in agreement with gravimetric 









































Fig. 17. Hydrated area relative to matrix cross-sectional area at different time points 




The thickness of the hydrated layer was determined in the axial and radial directions. 
Interestingly, the hydrated layer thickness in the radial direction was greater than that 
in the axial direction (Fig. 18A). This was particularly surprising since matrix axial 
swelling was greater than radial swelling (Fig. 14). Moreover, gel thickness was 
reported to be similar in both axial and radial directions (Moussa et al., 1998). Several 
mechanisms could have resulted in this scenario: (i) greater axial core expansion, (ii) 
hindered liquid diffusion in the axial direction due to formation of a less permeable 
barrier, (iii) easier liquid penetration in the radial direction through laminates 
formation, (iv) preferential radial erosion and, (v) predominant expansion of hydrated 
alginate particles in the direction of compression.  
 
In order to determine whether core expansion played a role in the apparent difference 
in the axial and radial hydrated layer thickness, the dimensions of the residual dry 
core were subsequently measured in the radial and axial directions. Fig. 18B shows 
decreasing radial core diameter with time and this corresponded to the increase in 
radial hydrated layer thickness, suggesting approximately constant solvent diffusion 
rate from the radial direction under acidic conditions. However, the axial dry core 
height did not change appreciably to be in tandem with the liquid front imbibing in 
the axial direction. In view of greater axial swelling of the entire matrix, the slower 
increase in axial hydrated layer thickness coupled with the almost-constant axial core 
height could be partly attributed to axial core expansion, which opposed axial solvent 
front movement towards the matrix center. This was shown by a slight increase in 
core dimension during initial hydration (Fig. 18B). Initial axial core expansion was 
more conspicuous for Manucol SS/LL matrices compared to Manucol LB matrices, as 

















































Fig. 18. (A) Thickness of hydrated layer and (B) dimensions of residual dry core 
measured in the axial (dotted lines) and radial (solid lines) directions for Manucol 

















































LB matrices due to its lower gel viscosity. This was not observed for Manugel DMB 
matrices due to enhanced liquid ingress brought about by crack formation. Even with 
radial core expansion, liquid penetration from the sides was still more rapid. Hence, 
radial core expansion could only be a transient phenomenon arising from residual 
elastic strain in the compacts. 
 
Although it had been suggested that the slower apparent liquid diffusion front 
movement from the axial direction was due to a simultaneous axial core expansion 
which opposed axial solvent front movement towards the matrix center, for a relaxed 
aged matrix, this contribution may not be as significant. Once the compression 
pressure is removed and the matrix ejected from the die, an instantaneous elastic 
recovery results in both axial and radial directions, followed by a slower anelastic 
strain recovery. Eventually, only irrecoverable plastic strain remained in the matrix 
(Goldhoff, 1971). Results obtained did not strongly support this theory as alginate 
matrices compressed to various porosities showed rather similar dissolution profiles 
(Fig. 4). Should the proposed core expansion be valid hindrance to liquid diffusion, it 
would be expected that denser compacted matrices showed slower drug release rates. 
This, however, was not found to be the case. Furthermore, it had been reported that 
axial elastic recovery of compacts increased with increasing compaction pressure 
(Alderborn and Nyström, 1984). Hence, with decreasing matrix porosity, axial core 
expansion is expected to increase, opposing liquid movement to greater extents. 
Nonetheless, matrix core expansion phenomenon had been observed by Rajabi-
Siahboomi et al. (1994) and Moussa et al. (1998). This discrepancy could be due to 
the difference in the polymer and gel barrier characteristics. 
 
 96
By the dynamics of compaction, volume change was largely in the axial direction. 
Thus, particulates undergoing compaction, especially alginate particles, experienced 
greater compression force in the axial orientation than radial direction and are 
expected to result into disc-shaped plastically deformed polymeric masses within the 
compact. By forming a more continuous gel layer, the flattened alginate particles were 
capable of collectively forming a less permeable liquid penetration barrier in the axial 
direction. Further liquid penetration in the axial direction was therefore retarded, 
resulting in slow decrease in the axial dry core dimension. In contrast, the radial 
direction allowed better liquid permeation via laminates formed by stacking of 
axially-compacted alginate particles. Evidence of this phenomenon can be seen by the 
occasional development of horizontal cracks or lamination in alginate matrices 
undergoing dissolution in the acidic phase, as shown by Manugel DMB matrices.  
 
As liquid ingress into the core from the axial front was impeded, continued hydration 
of the wetted layer resulted in its gradual growth due to swelling of the alginic acid 
barrier, which paralleled the absolute increase in overall axial dimension. Even 
though the polymer particles had been plastically-deformed, upon hydration, the 
increase in macromolecular mobility might allow polymer chains to regain their 
original molecular orientation, which is probably the preferred orientation. Further 
evidence for the propensity of matrices to swell mainly in the direction of 
compression was provided in a study by Colombo et al. (1992). In this study, HPMC 
matrices were partially coated with an impermeable film, either on the axial surface(s) 
and/or the radial surface followed by immersion in a hydrating medium. The swollen 
matrices showed preferential axial expansion even when both axial surfaces were 
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coated. Hence, predominant axial expansion was still observed even when liquid 
penetration was prevented in the axial direction. 
 
Studies have used the apparent gel front as a proxy for the apparent solvent 
penetration front (Gao et al., 1996). This was possible because the apparent gel front 
was found to be synchronized to the true solvent penetration front (Gao and Meury, 
1996). However, the apparent gel front lagged behind the solvent penetration front 
because glassy-to-rubbery transition of the polymer only takes place when the solvent 
concentration threshold value is reached.  
 
The incorporation of a dye into alginate matrices allowed direct determination of the 
apparent solvent penetration front since the dye front followed the solvent penetration 
front closely. Moreover, the extent of alginate matrix erosion in the acid phase was 
limited. The hydrated layer thickness in the radial direction can be used to represent 
the apparent solvent penetration front in acid since radial swelling was approximately 
constant with time. Solvent penetration occurred linearly into Manucol SS/LL and 
Manugel DMB matrices and exponentially into Manucol LB matrices (Fig. 18A) and 
the equations describing the aforementioned trends are given in Table 16. The faster 
radial liquid penetration in Manucol LB matrices was due to its lower acid gel 
viscosity. Circumferential erosion by the swirling dissolution medium caused faster 
surface remodeling and the dissipation of swollen gel matrix by erosion assisted in the 
development of a less compact gel layer. In addition, the swirling dissolution medium 
around the circumferential region of the matrix imparted some gentle centrifugal pull 
on the radial gel layer which was more likely to affect the lower viscosity gel formed 
by Manucol LB alginate. These effects manifested with the marginally less hindered 
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liquid penetration in the radial direction to bring about the observed exponential 
growth in the measured radial hydrated layer with time (Fig. 18A) for Manucol LB 
matrices. For Manucol SS/LL matrices, the higher viscosity gel layer did not respond 
to the small but perceptible environmental influences on the dissolving matrix and the 
hydrated layer developed in a linear manner, both in the axial and radial fronts. The 
rate of radial liquid penetration into Manugel DMB matrices was twice as fast as that 
of Manucol SS/LL matrices, illustrating the impact of matrix lamination on barrier 
integrity. The radial solvent penetration kinetics did not agree with the results from 
liquid uptake, swelling and hydrated area measurements. However, these three 
parameters take into consideration liquid penetration from all directions while radial 
solvent penetration front was only measured from the radial direction. The axial 
solvent penetration front appeared to progress slower than the radial solvent front 
(Table 16). The differences in solvent penetration rates in axial and radial directions 
could be attributed to the anisotropic behavior of matrices during dissolution.  
 
 
Table 16. Equations describing movement of apparent solvent penetration front within 
hydrating alginate matrices at pH 1.2. Y is the solvent penetration front in mm and X 
is time of hydration in hour. 
 
Equation Alginate grade 
 Radial direction Axial direction 
Manucol LB Y = 0.55 e 0.90 X Y = 0.51 X + 0.61 
Manucol SS/LL Y = 1.03 X + 0.25 Y = 0.63 X + 0.30 





A2.3 Crack development in alginate matrices 
The development of cracks in Manugel DMB matrices has been shown to increase the 
rate of drug release at pH 1.2 by compromising the integrity of the diffusion barrier. 
Crack formation is associated with the formation of alginic acid barrier as it is only 
observed at acidic pH. Matrices immersed in pH 6.8 dissolution media remained 
intact and formed smooth, viscous gel barrier. In contrast to alginic acid, sodium 
alginate gel is better able to accommodate swelling pressure due to imbibed liquid 
because of its viscous nature. Alginic acid is non-adhesive and shows minimal 
swelling. As more liquid imbibes into the matrix, the barrier is subjected to increasing 
tension and is forced to crack.  
 
Although barrier property and swelling were implicated in the crack development 
process, these factors cannot explain the pattern of crack formation. Cracks were 
observed to develop predominantly on the radial surface of the matrix tablets (Fig. 
3B). The underlying cause for this phenomenon lies in the inherent mechanical 
anisotropy of tablets imparted during the compaction process. The process of powder 
compaction is an inherently anisotropic process as the material is confined radially by 
a rigid die while being compressed axially by the moving punch or punches (Moe and 
Rippie, 1997). Crushing, plastic flow, and wedging of particles result in both radial 
and axial stresses and strains in the compact, but because of the highly directional 
nature of the process, these are expected to be functions of direction, resulting in 
compacts with anisotropic structure (Moe and Rippie, 1997). The anisotropy in 
compact structure is reflected in the non-uniform distribution of porosity within 
compacts (Kadiri et al., 2005; Eiliazadeh et al., 2003; Charlton and Newton, 1985) as 
well as in the observed differences between axial and radial tensile strengths of tablets 
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(Mullarney and Hancock, 2006; Malamataris et al., 1996). The axial porosity gradient 
could have caused non-uniform hydration and swelling of alginate particles along the 
axis of the matrix, resulting in local heterogeneity in distribution of stress and strain 
which gave rise to cracks within the rigid alginic acid barrier. Weaker tablet tensile 
strength in the axial direction relative to the radial direction (Mullarney and Hancock, 
2006; Malamataris et al., 1996), couple with the tablet density gradient along the axial 
direction, was likely to contribute to preferential axial swelling observed in hydrating 
polymer matrix systems. Predominant axial swelling of alginate matrix created greater 
tension within the alginic acid barrier on the radial surface along the axial direction, 
leading to the observed crack patterns.  
 
Furthermore, enhanced liquid permeation through laminates formed by stacks of 
axially-compacted alginate particles could have exacerbated crack development, as 
postulated earlier (Fig. 18A). 
 
Crack development was exacerbated in matrices consisting of G-rich alginates. This 
was likely to be associated with the inherent rigidity of G-blocks (Smidsrød et al., 
1973; Whittington, 1971). G-rich alginates formed stiffer gels relative to M-rich 
alginates. The rigid G-blocks could have contributed to regions of non-uniform 
swelling. Conversely, the higher flexibility of M-rich alginates probably allowed more 
uniform swelling and pressure distribution within the alginic acid barrier.  
 
B. Impact of hydration behavior on drug release from alginate matrices 
Alginate viscosity has been shown to affect initial polymer hydration during the 
barrier formation stage at pH 1.2. Higher extent of initial liquid uptake was shown by 
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Manucol LB matrices relative to Manucol SS/LL matrices. This was reflected by 
higher initial axial swelling and % hydrated area (Table 14). Rapid polymer hydration 
at pH 1.2 allowed quicker formation of an intact diffusion barrier. This contributed to 
lower rates of drug release at pH 1.2 from matrices consisting of lower viscosity 
alginate. Lamination of high-G alginate matrices affected the integrity of the alginic 
acid barrier. This was reflected by enhanced liquid penetration into the matrix and 
rapid drug release at pH 1.2 (Table 14). 
 
At pH 6.8, drug release was 3 times slower from Manucol SS/LL matrices relative to 
Manucol LB matrices (Table 14). The extent of matrix erosion from Manucol LB 
matrices was almost 3 times higher than Manucol SS/LL matrices due to shorter chain 
lengths of Manucol LB which disentangled and dissolved more readily. Matrix 
erosion resulted in reduced matrix dimension in both axial and radial directions and 
decreased the diffusion path-length for drug molecules, giving rise to higher release 
rates. On the other hand, increased retention of the viscous swollen gel layer of 
Manucol SS/LL matrices increased diffusion path-length of the drug. Although the 
rate of matrix erosion at pH 6.8 was twice as high for Manugel DMB as it was for 
Manucol SS/LL, the rate of drug release was only slightly higher for the former. The 
low drug release rate for Manugel DMB matrices could be due to reduced drug 
concentration gradient across the diffusion barrier as 60 % of drug was released in the 
previous acidic phase. 
 
Curve fitting studies showed that drug release in the acidic phase followed the 
Higuchi square root of time equation for Manucol LB and Manucol SS/LL matrices. 
When curve-fitted to the power law, n values (n represents the diffusional exponent of 
 102
the power law which is indicative of drug release mechanism) close to 0.45 (0.52 ± 
0.05 for Manucol LB matrices; 0.43 ± 0.02 for Manucol SS/LL matrices) were 
obtained, indicating drug release via Fickian diffusion. Upon pH change, drug release 
profiles followed zero order kinetics. Hence, drug was released predominantly by 
Fickian diffusion in acid and was erosion or swelling-controlled in the pH 6.8 buffer 
phase. This was expected since surface sodium alginate was converted to insoluble 
alginic acid which showed limited swelling, liquid uptake and erosion in the acid 
phase. Therefore, drug was predominantly released via diffusion through the alginic 
acid gel barrier. In contrast, Manugel DMB showed linear drug release at pH 1.2. 
Progressive crack formation led to increasing surface area which compensated for 
increasing drug diffusion pathway, resulting in linear drug release from Manugel 
DMB matrices. Hence, extensive matrix lamination influenced the kinetics of drug 
release from alginate matrices. However, percentage liquid uptake, axial swelling or 
erosion profiles for Manugel DMB matrices at pH 1.2 showed better fit to the Higuchi 
equation compared to the zero order equation. Upon pH change, alginic acid was 
reconverted to soluble sodium alginate which showed greater swelling, liquid uptake 
and erosion. Zero order release can be attributed either to a case II transport (swelling- 
or relaxation-controlled system) or an erosion-controlled system. For Manucol LB 
matrices, erosion was more likely to predominate while both erosion and swelling 
contributed to release from Manucol SS/LL and Manugel DMB matrices at pH 6.8. 
Drug release profile at pH 6.8 for Manugel DMB matrices was better described by the 
Higuchi model (Table 14). This was caused by depleting drug content since 60 % of 
drug was released at pH 1.2. Anisotropy in matrix swelling and liquid penetration 
suggests non-uniform drug release from different parts of the matrix and this could be 
important in modeling studies. 
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PART 3. FORMULATION STRATEGIES TO IMPROVE THE SUSTAINED-
RELEASE PERFORMANCE OF ALGINATE MATRICES 
Crack development in alginate matrices, particularly those consisting of high-G 
alginates, severely compromised the drug release performance of these matrices at 
acidic pH. It was hypothesized that modification of the diffusion barrier properties, 
via cross-linking or micro-environmental pH modification, can be employed to 
impede crack development and enable sustained drug release to be achieved.  
 
 A. Impact of cross-linker on matrix performance 
Cross-linking can be achieved by incorporating calcium salts into alginate matrices or 
by immersing alginate matrices in a solution containing calcium ions. These two 
approaches may result in different mechanisms of diffusion barrier formation. The 
availability of calcium ions from incorporated calcium salts depends on the amount 
incorporated and their solubilities. Hence, salts of different solubilities were added at 
two concentrations. Dissolution studies for matrices containing calcium additives 
were carried out at pH 1.2 followed by pH 6.8. In addition, dissolution was carried out 
in pH 6.8 media (without preceding acid phase) to remove competition with hydrogen 
ions as well as to prevent acid-induced matrix lamination. The impact of external 
calcium source was examined by performing dissolution studies of alginate matrices 
in calcium chloride solutions of varying concentrations. As cross-linking is influenced 
by the MG ratio of alginates, high-M (Manucol SS/LL) and high-G (Manugel DMB) 





A1. Influence of calcium salts incorporated into matrix tablets on drug release 
A1.1 Dissolution at pH 1.2 followed by pH 6.8 
In general, the incorporation of calcium salts into sodium alginate matrices did not 
significantly reduce drug release rates (Table 17). Being soluble in acid, calcium 
gluconate dissolved and leached out of the matrices, acting as a channeling agent to 
increase acid gel porosity. This effect was exacerbated at 20 % calcium gluconate 
content and even resulted in the disintegration of Manugel DMB matrices, leading to 
dose-dumping. For Manucol SS/LL matrices containing 20 % calcium gluconate, 
disintegration did not occur until pH-change was carried out, giving rise to the burst 
in release after pH-change. Even though calcium ions were available for cross-
linking, interaction with the alginate carboxylate groups was not favorable due to 
competition with hydrogen ions at pH 1.2. In addition, the channeling action of the 
soluble additive and the competition for water of hydration between the calcium salt 
and alginate disrupted the formation of a functional barrier. Manucol SS/LL matrices 
containing 5 % calcium gluconate did not show significant changes in the release 
profile. This was not the case in Manugel DMB matrices due to extensive matrix 
lamination which was enhanced even at 5 % additive concentration (Fig. 19A, B).  
 
The addition of dibasic calcium phosphate increased drug release rates from Manucol 
SS/LL matrices at pH 1.2. Being basic, dibasic calcium phosphate is acid-soluble, but 
its solubility is relatively low (approximately 1 % w/w at pH 1.2). The relatively 
insoluble particles could act as a physical coat to disrupt barrier formation by 
preventing the coalescence of neighboring alginate particles during hydration, as well 
as causing non-uniform swelling of the hydrating gel barrier. Hence, drug release 
from Manucol SS/LL matrices increased with higher amounts of dibasic calcium 
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phosphate. The presence of dibasic calcium phosphate in Manucol SS/LL matrices 
was observed to intensify crack formation (Fig. 20C). On the other hand, the presence 
of 20 % additive reduced drug release from Manugel DMB matrices. These matrices 
showed extensive crack formation at pH 1.2 (Fig. 19A). Given such extensive crack 
formation, the influence of dibasic calcium phosphate on swelling and barrier forming 
process might be negligible (Fig. 19C). On the contrary, the presence of insoluble 




Table 17. Effect of calcium salt inclusion on drug release rates of Manugel DMB or 
Manucol SS/LL matrix at pH 1.2 (2 h) followed by pH 6.8.  
 
Rate of drug release (% min-1) a 
Manugel DMB Manucol SS/LL 
 
Calcium salt additive 
pH 1.2 pH 6.8 pH 1.2 pH 6.8 
None (Control) 0.51 (0.01) 0.13 (0.01) 0.23 (0.01) 0.11 (0.00) 
5 % calcium gluconate 0.71 (0.01)b c 0.24 (0.01) 0.07 (0.00) 
20 % calcium gluconate 1.31 (0.06)b c 0.41 (0.01)b 0.58 (0.06)b 
5 % dibasic calcium phosphate 0.54 (0.01) 0.18 (0.01)b 0.32 (0.01)b 0.08 (0.00) 
20 % dibasic calcium phosphate 0.41 (0.01)b 0.17 (0.01)b 0.43 (0.01)b 0.15 (0.01) 
5 % calcium carbonate 0.48 (0.01) 0.19 (0.01)b 0.27 (0.01) 0.13 (0.01) 
20 % calcium carbonate 0.36 (0.01)b 0.21 (0.02)b 0.26 (0.01) 0.23 (0.01) 
 
a Curve-fitting to zero order equation was carried out separately for profiles in pH 1.2 
and pH 6.8, up to 90 % drug release.  
b Significantly different compared to control (P < 0.05). 
c Curve-fitting was not carried out as 80-90 % of drug was released at pH 1.2. 
 106
                                    
                       Fig. 19. Morphology (radial view) of Manugel DMB matrices with or without calcium salts in pH 1.2 dissolution media. 
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              Fig. 20. Morphology (radial view) of Manucol SS/LL matrices with or without calcium salts in pH 1.2 dissoloution media.
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When 20 % calcium carbonate was added to Manugel DMB matrices, drug release 
was retarded at pH 1.2. Matrices with 5 % additive showed similar drug release 
profile as the control matrices in the acidic phase. Carbon dioxide bubbles were 
formed rapidly on the surface when placed in acidic medium due to the reaction 
between calcium carbonate and acid. This layer of bubbles formed a physical barrier 
to further reduce acid ingress and drug egress and was only effective at 20 % additive 
level. The markedly reduced extent of lamination of Manugel DMB matrices in acid 
suggests that the physical barrier formed by carbon dioxide bubbles slowed down 
liquid penetration into the matrices and reduced the conversion of sodium alginate to 
alginic acid, which had a tendency to laminate (Fig. 19D). Manucol SS/LL matrices 
containing 5 and 20 % calcium carbonate showed similar drug release profiles as the 
control matrices in the acidic phase. The air bubble-barrier formed did not confer 
additional protection against acid ingress and this was probably due to the relatively 
intact barrier formed by Manucol SS/LL alginate in acid.  
 
A1.2 Interaction between alginate and calcium ions at pH 6.8 
The availability of calcium ions from sparingly soluble calcium additives for cross-
linking was investigated via viscosity studies using dilute solutions of Manugel DMB 
alginate (0.1 % w/w), with and without calcium additives. Calcium carbonate or 
dibasic calcium phosphate was added in excess to dilute alginate solutions prepared in 
pH 6.8 dissolution media. In a previous study, viscosity reduction was brought about 
by the removal of viscosity-imparting alginate polymer from the solution by 
interaction with calcium ions to form insoluble calcium alginate (Chan et al., 2002). 
Hence, reduction in flow time of alginate solution was used as an indicator of calcium 
alginate formation. It was found that the flow time of alginate solution was not 
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significantly changed with the addition of sparingly soluble calcium salts or soluble 
calcium chloride in pH 6.8 media (Table 18). This could be attributed to the 
abundance of sodium and phosphate ions in the solution, competing for binding with 
alginate and calcium ions, respectively. Viscosity studies were repeated with dilute 
sodium alginate solution in deionized water. Flow time measurements were markedly 
reduced in the presence of sparingly soluble calcium additives (Table 18), indicating 
availability of calcium ions for cross-linking with sodium alginate. These findings 
suggest that calcium-alginate interaction was unlikely to occur in pH 6.8 dissolution 
media. It was possible that the conditions employed in the viscosity study did not 
reflect the actual micro-environmental conditions within a hydrating alginate matrix. 
Chelation of free calcium ions by phosphate ions might be limited due to limited 
diffusion of phosphate ions into the matrix. The occurrence of cross-linking would be 
reflected by differences in drug release rates obtained from different alginate grades 
since high-M alginates are relatively insensitive to calcium ions.   
 
Table 18. Influence of calcium salt on flow time of dilute sodium alginate solution. 
 
Average flow time (min) Calcium salt additive a 
pH 6.8 buffer Deionized water 
None (negative control) 
Calcium carbonate 
Dibasic calcium phosphate 










a Amount of calcium salt added was 0.1 g/ 100 g of sodium alginate solution. 
b Significantly different compared to the respective negative control (P < 0.05).  
c The flow time of dilute sodium alginate solution (negative control) was lower in pH 
6.8 buffer compared to that in deionized water. The solvent ionic strength was higher 
in the former (0.375 M versus ~ 0 M). At higher ionic strength, the intermolecular 
electrostatic repulsion between negatively charged alginate chain segments was 
reduced due to charge screening by positive counterions, reducing the polymer coil 
dimension (Zhang et al., 1998; Dentini et al., 2005). This resulted in lower polymer 
solution viscosity (Miller-Chou and Koenig, 2003). 
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A1.3 Dissolution at pH 6.8  
The incorporation of water-soluble calcium gluconate into alginate matrices at the 
concentrations used did not retard drug release. At 5 % calcium gluconate 
concentration, drug release profiles were similar to those of control matrices. When 
20 % calcium gluconate was added, drug release from alginate matrices was 
accelerated, and the effect was greater for Manugel DMB matrices (Table 19). Instead 
of cross-linking with alginate, the liberated calcium ions could have been sequestered 
by phosphate ions in the dissolution medium. However, calcium ion sequestration was 
not the only factor involved, as dissolution of Manugel DMB matrices containing 20 
% calcium gluconate in distilled water showed increased drug release as well.  
 
 
Table 19. Effect of calcium salt inclusion on drug release rates from Manugel DMB 
or Manucol SS/LL matrix at pH 6.8. Dissolution of Manugel DMB matrices 
containing 20 % calcium gluconate was also carried out in distilled water.  
 
Rate of drug release (% min-1) a  
Calcium salt additive Manugel DMB Manucol SS/LL  
None (Control) 0.09 (0.00) 0.12 (0.00) 
5 % calcium gluconate 0.10 (0.00) 0.10 (0.00) 
20 % calcium gluconate 1.24 (0.04)b 0.25 (0.01)b 
5 % dibasic calcium phosphate 0.10 (0.00) 0.11 (0.00) 
20 % dibasic calcium phosphate 0.10 (0.00) 0.11 (0.00) 
5 % calcium carbonate 0.14 (0.01) 0.10 (0.00) 
20 % calcium carbonate 0.22 (0.01)b 0.10 (0.00) 
 






5% micronized dibasic calcium phosphate 








a Drug release rate was determined by curve-fitting to zero order equation. 
b Significantly different compared to control (P < 0.05).  
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The effect of calcium gluconate was greater in Manugel DMB matrices compared to 
Manucol SS/LL matrices (Table 19). This was surprising as the high-G alginates 
formed more rigid gels that are more resistant to erosion than high-M alginates (Veski 
and Marvola, 1993). The greater rigidity of G-rich alginate gels is due to the higher 
proportion of rigid G-blocks compared to the more flexible M-blocks (Draget et al., 
2006; Lee et al., 2002) as illustrated by the higher calculated persistence length of 
polyguluronic acid compared to polymannuronic acid (Braccini et al., 1999). Hence, 
drug release was slower from Manugel DMB control matrices compared to that of 
Manucol SS/LL matrices (P < 0.05). However, in the presence of calcium gluconate, 
this was no longer the case. Even with greater gel rigidity, Manugel DMB was less 
tolerant to the disruptive effects of these additives. For a functional diffusion barrier 
to form, dry sodium alginate particles have to hydrate sufficiently and coalesce. The 
rapid release of calcium ions resulted in rapid formation of calcium alginate, before 
sodium alginate particles could swell and fuse together to form a continuous barrier. 
Lower extent of cross-linking in a high-M alginate would allow better overall 
hydration of alginate polymer to form a sufficiently intact barrier. In contrast, 
extensive cross-linking of high-G alginate reduced the overall hydration and fusion of 
the polymer particles. The rapid formation of non-binding calcium alginate in the 
midst of intense channeling action by soluble calcium gluconate resulted in 
aggregates of calcium alginate precipitates, which detached readily from the matrix 
surface. Hence, drug release was accelerated, especially from Manugel DMB 
matrices, as cross-linking contributed to increased matrix erosion, rather than 
reinforcing barrier function. These findings are in contrast to previous studies (Azarmi 
et al., 2003; Nokhodchi and Tailor, 2004) which employed soluble calcium chloride 
dihydrate as the cross-linker. In the present study, matrices containing calcium 
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chloride were not used as the matrices were too “wet” and sticky due to the 
hygroscopicity of the calcium salt. This made handling of the matrices difficult and 
might give rise to less accurate results.   
 
Dibasic calcium phosphate and calcium carbonate are practically insoluble in pH 6.8 
buffer. Despite being insoluble, both types of additives gave rise to contrasting effects 
on drug release. Dibasic calcium phosphate had marginal influence on the drug 
release profiles at 5 and 20 % concentrations in both types of alginate matrices. In 
contrast, addition of calcium carbonate increased drug release rate from Manugel 
DMB matrices. Dibasic calcium phosphate had a median particle size of 180 μm 
while calcium carbonate particles were about 4 μm. The effect of particle size of 
dibasic calcium phosphate was tested by evaluating the dissolution performance of 
Manugel DMB and Manucol SS/LL matrices containing micronized dibasic calcium 
phosphate (median particle size of approximately 3.5 μm). Surprisingly, these 
matrices showed rather similar drug release profiles as those containing larger dibasic 
calcium phosphate particles (Table 19). Apparently, the particle size of dibasic 
calcium phosphate did not affect the function of the alginate gel barrier at pH 6.8. 
Contact angles of water on pure compacts of dibasic calcium phosphate or calcium 
carbonate were 31° and 30°, respectively (Odidi and Newton, 1993), indicating that 
both types of calcium salts showed similar wettabilities. Hence, the incorporation of 
these calcium salts was not likely to affect the wetting of alginate matrices to different 
extents. Dibasic calcium phosphate and calcium carbonate are sparingly soluble in 
water (0.2 g/L and 0.014 g/L, respectively) (Baden, 2000). However, in pH 6.8 
dissolution media, the abundance of phosphate ions would suppress the ionization of 
dibasic calcium phosphate due to common ion effect. Although limited, calcium ions 
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from the ionization of calcium carbonate within the alginate matrix could have 
resulted in calcium alginate formation. Considering the limited solubility of calcium 
carbonate, cross-linking was likely to be restricted to the immediate vicinity of the 
dissolving salt, resulting in microscopic calcium alginate patches which hindered 
uniform hydration of surface alginate, compromising the formation of an integral gel 
barrier. Increased drug release was only observed with the high-G Manugel DMB 
matrices containing calcium carbonate as calcium ions preferentially binds to 
guluronate segments. The apparent lack of gel barrier disruption in Manucol SS/LL 




A2. Effect of external calcium source on drug release from alginate matrices  
Dissolution of sodium alginate matrices (without calcium salt) was carried out in 
media containing various concentrations of calcium chloride. The aim of this study 
was to determine whether sustained drug release could be attained from externally 
cross-linked alginate matrices. Without cross-linking, drug release from Manugel 
DMB and Manucol SS/LL matrices was complete at 9 and 7 h, respectively, whereas 






















































Fig. 21. The influence of external calcium source at 0 M (water) (○), 0.01 M (□), 0.05 
M (■), 0.1 M (∆), 0.2 M (▲) and 0.5 M (◊) on drug release profiles from (A) 







































A2.1 Influence of calcium ion concentration on drug release 
Besides varying the availability of calcium ions for cross-linking, varying calcium ion 
concentrations also affected the ionic strength of the dissolution media. Hence, the 
influence of ionic strength on drug release from sodium alginate matrices was 
investigated by conducting dissolution studies in sodium chloride solutions of 
equivalent ionic strengths using Manugel DMB matrices (Table 20). Clearly, drug 
release was affected by the solution ionic strength (Fig. 22). However, drug release 
kinetics differed in the presence of cross-linkers (Fig. 21A). Dissolution profiles 
during early stages of drug release were examined to elucidate the influence of ionic 
concentration on the mechanism of diffusion barrier formation. In general, drug 
release during the initial hour was slower at lower ionic concentrations (Fig. 21A; Fig. 
22). This suggests that the gel barrier formation was influenced by solution ionic 
strength, in addition to cross-linking. A reduction in polymer-solvent interaction was 
postulated to result in decreasing polymer solubility with increasing solution ionic 
strength (Cho et al., 2006). Hence, higher concentration of ions in the vicinity could 
have reduced the hydration rate of surface alginate due to competition for water of 
hydration, and subsequently slowed down the formation of an intact gel barrier. 
Furthermore, as calcium ion concentration increased, surface sodium alginate was 
more rapidly cross-linked which hindered further polymer swelling. Initial polymer 
hydration, swelling and coalescence were important to occlude surface pores and 
minimize barrier permeability. Hence, the permeability of the initial barrier formed 
was greater at higher calcium ion concentration, resulting in faster initial drug release. 
Initial drug release from matrices immersed in 0.01 M calcium chloride solution was 
similar to that of control matrices, indicating that gel barrier formation was not 
significantly compromised at this cross-linker concentration.  
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Ionic strength a (M) Sodium chloride concentration of 
equivalent ionic strength (M) 
0.01 0.03 0.03 
0.1 0.3 0.3 
0.2 0.6 0.6 
0.5 1.5 1.5 
 
a Ionic strength, I = ½ Σ ci zi2 where ci is the ionic concentration in units of molarity 
and zi is the number of charges on the ion (Maron and Lando, 1974). 
 
The importance of rapid polymer hydration in establishing a functional diffusion 
barrier was illustrated by the disintegration of alginate matrices at high concentrations 
of salts. At 0.5 M and 1.5 M calcium chloride and sodium chloride concentrations, 
respectively, the hydration of alginate polymer was severely hindered due to 
competition with the salts for water molecules, resulting in compromised swelling and 
coalescence of viscous alginate particles to form a continuous barrier. Without rapid 
polymer particle swelling to occlude the surface pores, liquid uptake by capillary 
forces was enhanced. At the same time, rapid interaction of calcium ions with alginate 
resulted in non-binding particles, which could have further compromised the 
formation of an integral barrier. Hence, without an integral barrier, the rapid influx of 
liquid into the matrix interior was possible and the rapid development of swelling 
pressure from within forced the matrix to disintegrate. Catastrophic failure of alginate 
matrices at high calcium ion concentration in acidic medium was reported by 
Hodsdon et al. (1992) and the cause was attributed to impeded swelling of polymer 
particles due to conversion to alginic acid and calcium alginate. Since alginate matrix 
disintegration also occurred at 1.5 M sodium chloride concentration, the cause was 
more likely to be due to the high ionic strength of the dissolution medium and not the 























Fig. 22. The influence of ionic strength (adjusted using sodium chloride) on drug 
release from Manugel DMB matrices. Ionic strengths used were 0 M (water)(○), 0.03 





Drug release in the later phase (after 2.5- 4 h) was generally higher at lower calcium 
ion concentration (Fig. 21). With increasing immersion time, the barrier thickness as 
well as the extent of cross-linking increased resulting in reduced barrier permeability, 
particularly at higher calcium ion concentrations.  
 
In fundamental studies of alginate gelation, it was observed that increasing 
concentrations of calcium ions affected the equilibrium gel strength of calcium 
alginate gel. As the amount of calcium ion increased, gel rigidity increased up to 40 % 
calcium conversion. Calcium conversion beyond 40 % resulted in the formation of 
precipitated complexes instead of a homogeneous gel (Papageorgiou et al., 1994). 
Hence, the slowest overall drug release obtained at 0.1 M calcium chloride 
concentration could be due to optimum association between alginate and calcium 
ions, leading to a cohesive network structure of junction zones and hydrated/dissolved 
segments. Higher concentrations of calcium chloride (0.2 and 0.5 M) led to the 
formation of precipitated structures with inferior network-forming capacity that were 
less effective in retarding drug release or in maintaining matrix integrity. 
 
A2.2 Liquid penetration study to elucidate mechanism of drug release 
To further examine the influence of calcium ion concentration on barrier formation, 
solvent penetration studies were carried out using Manugel DMB matrices with the 
aid of a dye. The overall percent liquid uptake per unit weight of matrix remaining 
was markedly reduced by cross-linking (Fig. 23A). The reduced capacity of cross-
linked alginate matrices to imbibe liquid was due to the insolubility of calcium 
alginate. Matrices immersed in 0.01 and 0.1 M calcium chloride solutions showed 



























Fig. 23. The profiles of (A) liquid uptake, (B) matrix swelling and (C) matrix erosion 
of Manugel DMB matrices in water (○, ●) as well as in 0.01 M (□, ■) and 0.1 M (∆, 
▲) calcium chloride solutions. Swelling in the axial and radial directions is denoted 



































































liquid uptake was due to hydration of sodium alginate prior to the formation of 
calcium alginate barrier. Greater extent of initial liquid uptake by matrices immersed 
in 0.01 M solution was reflected by higher overall matrix swelling compared to 
matrices immersed in 0.1 M solution (Fig. 23B). This was not the case for control 
matrices as polymer dissolution reduced the apparent matrix swelling.  
 
 
The higher extent of initial (2 h) liquid uptake for matrices immersed in 0.01 M cross-
linker solution relative to that observed in 0.1 M cross-linker solution (Fig. 23A) 
suggested higher extent of polymer hydration in the former. This was supported by 
image analysis studies of matrix cross-sections (Fig. 24) which showed that matrices 
immersed in 0.01 M cross-linker solution had larger hydrated area (Fig. 25). As the 
apparent dry core area was similar for matrices immersed in both 0.01 and 0.1 M 
solution, the larger hydrated area of matrices immersed at 0.01 M cross-linker 
solution implied that the liquid imbibed by matrices during this stage was used to 
swell the alginate polymer within the hydrated area. This suggests that higher cross-
linker concentration reduced the extent of polymer hydration, as mentioned in the 
preceding section, giving rise to faster initial drug release from matrices cross-linked 



















Fig. 24. Axial cross-sections of Manugel DMB matrices containing methylene blue 



































Fig. 25. Hydrated (closed symbol) and apparent dry core (open symbol) area of matrix 





The gradual decline in the rate of drug release from cross-linked matrices can be 
attributed to minimal matrix erosion (Fig. 23C) which resulted in increasing drug 
diffusion path length. The role of matrix preservation is evident in the linear drug 
release profiles observed with the control matrices (Fig. 21). Gradual dissolution of 
sodium alginate matrix (Fig. 23C) removed the drug-depleted outer layer and 
maintained a constant diffusion barrier thickness which allowed for a pseudo-zero 
order drug release. Moreover, increasing extent of cross-linking resulted in the 
formation of tighter polymer networks that retarded drug release. During gelation, 
polymer chains undergo contraction during their transition from sol to gel state 
(Woelki and Kohler, 2003). Interaction with calcium ions draws the alginate 
molecules closer together, facilitating hydrogen bonding which promotes gel 
consolidation (King, 1983). This was shown by matrix consolidation upon complete 
wetting of the matrix core (4.2 and 12. 3 % reduction in cross-sectional area from 3 – 
6 h for matrices immersed in 0.1 and 0.01 M calcium chloride solution, respectively) 
(Fig. 25). The minimal drug loss (1.4 and 2.1 % at 0.1 and 0.01 M calcium chloride 
concentration, respectively) and minimal change in matrix erosion (0.8 and 1.7 % at 
0.1 and 0.01 M calcium chloride concentration, respectively) during this stage (3 -6 h) 
was unlikely to have caused the reduction in total cross-sectional area.  
 
Reduction in cross-sectional dry core area occurred linearly to similar extents despite 
differences in dissolution media (Fig. 25), suggesting that liquid penetration was not 
the rate-limiting factor in matrix wetting. However, the rate of polymer hydration and 
swelling is dependent on the availability of free water molecules, which is determined 
by the dissolution media composition. At low solute concentration, polymer hydration 
was relatively unhindered, as shown by higher extent of hydrated area in water and at 
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0.01 M calcium chloride concentration (Fig. 25). Rapid hydration of polymer allowed 
rapid formation of an intact gel barrier for better initial retardation of drug release 
(Fig. 21). Therefore, it is not the rate of liquid penetration, but the rate of polymer 
hydration that determines the drug release characteristics from a matrix system. 
 
 
A2.3 Influence of alginate grade on drug release 
In the presence of calcium ions, Manugel DMB matrices showed slower overall drug 
release than Manucol SS/LL matrices and this was only observed at 0.01 and 0.05 M 
calcium chloride concentration, the difference being more obvious at the lower 
concentration (Table 21). Visual observation showed extensive swelling and crack 
formation in Manucol SS/LL matrices (Fig. 26A), the extent of which was greater for 
matrices immersed in 0.01 M compared to 0.05 M cross-linker solution. The presence 
of cracks could have enhanced drug release from these matrices. In contrast, Manugel 
DMB matrices remained intact (Fig. 26A). Calcium alginate formed from high-G 
alginates are mechanically stronger (Skjåk-Bræk, 1992; Mancini et al., 1999) and 
hence, more capable of withstanding swelling pressure. Despite the presence of 
cracks, drug release was still sustained (Fig. 21). Rupture of the calcium alginate 
barrier resulted in the leakage of viscous sodium alginate from the inner hydrated 
layer, which gelled as it came into contact with calcium ions. This resulted in the 
formation of a gelatinous mass at the cracked region (Fig. 26A) which effectively 
sealed the crack, preserving the diffusion barrier. The presence of hydrated sodium 
alginate within the matrix was likely as the incoming calcium ions were sequestered 
upon contact with available binding sites in the alginate polymer while water 
molecules continued to imbibe further into the sodium alginate matrix. This ‘self-
sealing’ mechanism enabled continued drug release retardation from such matrices. A 
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study on coated pellets showed that the pressure built-up in the region away from the 
punctured site pushed the core material towards the point of puncture, sealing the exit 
point caused by pellet coat rupture (Heng et al., 1999). This phenomenon of ‘shifting 
core’ due to uneven pressure distribution could have contributed to the leakage of 
polymer in alginate matrices.  
 
At 0.1 M cross-linker concentration, dissolution profiles from both types of alginate 
matrices were similar. At this concentration, the effect of alginate chemical 
composition was not apparent as ionic strength effect came into play. The reduced 
rate of alginate hydration at higher ionic strength could have masked the influence of 
alginate chemical composition on gel barrier property. Interestingly, Manucol SS/LL 
matrices disintegrated at 0.2 M calcium ion concentration while Manugel DMB 
matrices remained intact. More extensive cross-linking of minimally hydrated 
polymer in the latter probably kept the matrices intact. 
 
 
Table 21. Influence of alginate grade on drug release rate from alginate matrices 
undergoing dissolution in calcium chloride solution.  
 
Higuchi rate constant a (% min-0.5) Calcium chloride concentration (M) 
Manugel DMB Manucol SS/LL 
0.01 3.20 (0.02) 5.24 (0.12) 
0.05 2.20 (0.02) 2.41 (0.10) 
0.1 2.10 (0.05) 2.14 (0.05) 
0.2 2.07 (0.07) - 
 
a Curve-fitting to the Higuchi equation was carried out for 20-80 % drug release  






(A)                
 
(B) 
             
                  
          
Fig. 26 (A) Appearance of (i) Manugel DMB and (ii) Manucol SS/LL matrices after 
24 h dissolution in 0.01, 0.05, 0.1 or 0.2 M calcium chloride solution; (B) Appearance 
of matrices at 110 min of dissolution at pH 1.2 for calcium alginate-coated Manugel 
DMB matrices cross-linked in 0.1 M calcium chloride solution for (i) 1.5 h, (ii) 1 h, 
(iii) 0.5 h or 0.01 M calcium chloride solution for (iv) 1.5 h, (v) 1 h and (vi) 0.5 h, 
respectively. 
(i)                      (ii)                     (iii) 
(iv)                      (v)                     (vi) 
1 cm 
(i)   0.01 M              0.05 M            0.1 M               0.2 M 
(ii)          0.01 M                    0.05 M                    0.1 M         
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A3. Dissolution performance of calcium alginate-coated matrices 
Results have shown that prolonged release of a highly water-soluble drug from 
alginate matrices can be achieved via in situ cross-linking using an external calcium 
source (Fig. 21). In addition, the integrity of Manugel DMB matrices was preserved.  
Calcium alginate-coated matrices were therefore prepared and tested under simulated 
gastrointestinal pH conditions. Such studies have not been reported. Manugel DMB 
was used in this part of the study as it showed minimal rupturing tendency relative to 
Manucol SS/LL matrices during dissolution in calcium chloride solution. Manugel 
DMB matrices were immersed in 0.1 and 0.01 M calcium chloride solution for 0.5, 1 
or 1.5 h and oven-dried overnight. Matrices were also immersed in distilled water to 
account for the effects of cross-linking as well as drug loss. However, these matrices 
stuck to the mesh due to the adhesive nature of sodium alginate and cracked upon 
drying. Hence, further investigations on these matrices were not carried out and 
Manugel DMB matrices without coating were used as the control. 
 
Dissolution studies showed markedly reduced drug release rates from the cross-linked 
matrices in the acidic phase (Fig. 27). Drug release at 2 h decreased from 60 % to 22 
% or less with cross-linking. Matrices cross-linked in 0.1 M calcium chloride solution 
showed lower drug release rates in the acidic phase than matrices treated in 0.01 M 
calcium chloride solution. Drug loss during cross-linking from these matrices was 




























Fig. 27. Drug release from calcium alginate-coated Manugel DMB matrices in pH 1.2 
(2 h) followed by pH 6.8 media. Matrices were previously cross-linked in 0.1 (closed 
symbol) and 0.01 M (open symbol) calcium chloride solutions for 1.5 h (□, ■), 1 h (∆, 
▲) or  0.5 h (◊, ♦) and dried prior to dissolution testing. Dissolution profiles of 
control matrices are denoted by (○).  
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Duration of immersion in 
cross-linking solution (h) 
Drug loss (%) Drug release rate in 
acid a (% min-0.5) 
    
0.5 7.7 (0.2) 1.29 (0.06)b 
1 11.4 (0.3) 0.99 (0.02)b 
0.1 
1.5 14.9 (0.7) 0.75 (0.03)b 
    
0.5 3.4 (0.3) 1.91 (0.06) 
1 6.8 (0.5) 1.83 (0.05) 
0.01 
1.5 9.9 (1.2) 1.86 (0.03) 
 
a Drug release rate was determined by curve-fitting to the Higuchi equation.  
b Significantly different compared to each other  
 
 
Greater extent of drug depletion from the outer layer of the matrix could have reduced 
the initial drug release rate due to increased diffusion path length as well as reduced 
drug concentration gradient for diffusion. In addition, matrices cross-linked for a 
longer duration had lower drug release rates in the acidic phase (P < 0.05) but this was 
only observed for matrices cross-linked in 0.1 M calcium chloride solution. 
Apparently, the amount of drug loss during cross-linking for different durations in 
0.01 M calcium chloride did not affect drug release at pH 1.2 significantly (P > 0.05). 
The different duration of cross-linking did not influence drug release too, probably 
due to minimal formation of cross-linkages within the short treatment duration at low 
calcium ion concentration. This suggests that the amount of drug loss within the 
reported range was unlikely to have an effect on drug release rate. Furthermore, drug 
release from matrices cross-linked in 0.01 M solution for 1.5 h was faster than that 
from matrices cross-linked in 0.1 M solution for 0.5 h, even though drug loss from the 
former was greater than the later (Table 22). Hence, the lower rate of drug release 
from matrices treated in 0.1 M calcium chloride solution as well as the decreasing 
drug release rate with increased treatment duration at this concentration was more 
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likely to be due to lower barrier permeability brought about by more extensive cross-
linking rather than drug depletion. This observation was also made in previous studies 
on alginate film permeability (Chan et al., 2006; Julian et al., 1988). For a highly 
water soluble drug, drug release is governed by the thickness and consistency of the 
diffusion barrier, and not just the mere distance of the drug from the bulk media. 
 
 
The cross-linked matrices remained relatively intact during dissolution at pH 1.2 (Fig. 
26B). In contrast, control matrices laminated extensively, leading to high drug release 
rates at this pH (Fig. 19A). Clearly, preservation of a continuous barrier in cross-
linked matrices during dissolution contributed significantly towards drug release 
retardation at pH 1.2. Preservation of the matrix structure also affected the shape of 
the drug release profiles at pH 1.2. Drug release from control matrices showed linear 
kinetics (Table 17) which can be attributed to increasing surface area exposed to 
dissolution media with time, brought about by matrix lamination. In contrast, drug 
release from cross-linked matrices followed square-root kinetics (Table 22), 
indicating diffusion-controlled drug release. This was not surprising since the calcium 
alginate-coated matrix retained its shape throughout dissolution at this pH (except for 
matrices cross-linked for 0.5 h in 0.1 M calcium chloride solution). 
 
Burst release was observed shortly after pH change and in the late acidic phase for 
matrices cross-linked in 0.1 M calcium chloride solution (Fig. 27). Burst release 
coincided with the appearance of cracks as shown in Fig. 26B (iii) for matrices cross-
linked for 0.5 h. The gradual conversion of calcium alginate to alginic acid at pH 1.2 
coupled with increasing matrix expansion caused the weaker alginic acid barrier to 
crack. As the swelling of the sodium alginate core was likely to be greater than the 
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outer alginic acid layer, an internal pressure was generated which caused the barrier to 
crack. These cracks continued to propagate with increased swelling pressure as the 
matrices entered the buffer phase, eventually triggering burst release as the cracks 
penetrated the core. The sudden increase in drug release that occurred in the late 
acidic phase (Fig. 27) did not persist as the exposed core was gradually sealed by the 
swelling sodium alginate layer. On the contrary, matrices cross-linked in 0.01 M 
calcium chloride solution remained intact for longer periods and only developed 
cracks in the early buffer phase (4-5 h). However, the cracks formed did not propagate 
as they were rapidly sealed by the swelling alginate core. Matrices cross-linked in 
0.01 M cross-linker solution for 1 h showed zero order kinetics from 20 to 80 % drug 
release. 
 
Evidence of the matrix core consisting mainly of sodium alginate was obtained from 
cross-sectional images of hydrated calcium alginate-coated matrices containing a pH 
indicator, bromophenol blue (Fig. 28). This indicator turns yellow when pH goes 
below 3, corresponding closely to the pH below which more than 50 % of sodium 
alginate is converted to alginic acid. The blue coloration of the matrix core beneath 
the coat (Fig. 28) indicates that the micro-environmental pH within the core was 
above 4.6. Therefore, the matrix core consisted mainly of sodium alginate. The coat 
surrounding the matrix was able to protect the core from being converted to alginic 
acid. The incoming protons from the acidic dissolution media underwent ionic 
exchange with calcium alginate to form alginic acid while water molecules continued 





Fig. 28. Cross-sectional images of calcium alginate-coated matrices hydrated for 1 h 
in pH 1.2 dissolution medium. Manugel DMB matrices containing bromophenol blue 
were pre-coated in (A) 0.01 M or (B) 0.1 M calcium chloride solutions, respectively 
for 1 h. 
 
 
B. Influence of pH-modifiers on alginate matrix performance 
The incorporation of pH-modifiers had been employed in matrix systems to enhance 
the dissolution rate of weakly acidic (Chakrabarti and Southard, 1997) or basic drugs 
(Tatavarti and Hoag, 2006; Varma et al., 2005; Streubel et al., 2000), However, no 
reported studies have employed pH-modifiers to influence the behavior of pH-
sensitive biopolymer matrices, specifically alginate compacts, in order to modify the 
drug release kinetics of such matrices. In this study, pH-modifiers were used to retard 
the conversion of sodium alginate to alginic acid in order to improve the preservation 
of matrix integrity during dissolution at gastric pH. The effect of pH-modifiers on 








B1. Influence of pH-modifiers on drug release from alginate matrices 
The incorporation of pH-modifiers decreased the overall drug release from alginate 
matrices (Table 23). Higher additive concentration gave rise to greater extent of drug 
release retardation at pH 1.2 (Table 23). The amount of drug released in the acidic 
phase (at 2 h) ranged from 20 to 45 %, a significant reduction compared to 60 % from 
control matrices (P < 0.05). Sodium acetate and tri-sodium phosphate exerted similar 
effects on drug release at pH 1.2 (P > 0.05). Although tri-sodium phosphate is more 
alkaline, its pH-elevating effect in acid was much lower than that of sodium acetate 
for the same weight of salt (Table 24) since fewer moles of tri-sodium phosphate was 
available to react with acid. The performance of matrices containing sodium 
bicarbonate was superior compared to the rest.  In addition to pH-modifying effects, 
carbon dioxide bubbles generated from the reaction between sodium bicarbonate and 
hydrochloric acid formed a physical air barrier around the matrix, providing a 
secondary layer of protection against the acidic environment.  
 
As mentioned earlier, extensive lamination of alginate matrices was noted in the 
acidic phase where sodium alginate was converted to alginic acid. This phenomenon 
was not observed at pH 6.8 where sodium alginate exists in its ionic form. Therefore, 
incorporation of pH-modifiers was postulated to reduce the extent of alginate 
protonation by raising the matrix micro-environmental pH, consequently minimizing 






Table 23. Influence of various salt additives on drug release from Manugel DMB 
matrices at pH 1.2 (2 h) followed by pH 6.8.  
 
Additive Concentration  Drug release rate b 
 (%) pH 1.2 (% min-1) pH 6.8 (% min-0.5) 
    
Control (without 
additive) 
0 0.51 (0.01) 4.51 (0.41) 
    
Sodium chloride 10 0.58 (0.01)a 3.36 (0.22) 
Sodium acetate  0.38 (0.01)a 3.65 (0.15) 
Tri-sodium phosphate  0.36 (0.01)a 3.98 (0.12) 
Sodium bicarbonate  0.24 (0.01)a 4.02 (0.08) 
    
Sodium chloride 20 0.51 (0.02) 3.72 (0.03) 
Sodium acetate  0.28 (0.00)a 3.71 (0.12) 
Tri-sodium phosphate  0.29 (0.00)a 4.13 (0.16) 
Sodium bicarbonate  0.17 (0.01)a 3.39 (0.07)a 
 
a Significantly different compared to control (P < 0.05) 
b Dissolution profiles at pH 1.2 or pH 6.8 (up to 90 % drug release) were curve-fitted  
  to zero order or Higuchi square root equations, respectively.  
 
 




pH in water 
(1 % w/w) 
pH in 
0.1N HCl 
(1 % w/w) 
Solubility in 
water (g/L)c 
     
Sodium chloride -8.0 a 7.19 1.09 358 
Sodium acetate 4.76 b 7.90 3.97 365 
Tri-sodium phosphate 2.16, 7.21, 12.32 b 11.99 1.69 285 
Sodium bicarbonate 6.35, 10.33 b 9.36 6.24 96 
Calcium carbonate 6.35, 10.33 b 8.45 5.88 0.014 
 




However, at pH > pKa of alginate, the polymer would exist mainly in its anionic form 
and might interact with the cationic model drug. However, electrostatic interactions 
are sensitive to the presence of other ions in solution. A study by Moreno-Villoslada 
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et al. (2005) found that chlorpheniramine maleate interacted with alginate at pH 7.5 in 
the absence of sodium chloride, but the interaction was prevented in the presence of 
sodium chloride due to screening effects and competition of large excess of sodium 
ions to bind the polyelectrolyte surfaces. Since the pH-modifiers used in this study are 
sodium salts, electrostatic interaction between the model drug and alginate was 
prevented and was unlikely to play a significant role in retarding drug release. 
 
On the other hand, if micro-environmental pH is 7.13 and beyond, conversion of 
chlorpheniramine maleate to its free base (pKa 9.13) (Moffat et al., 1986) will occur. 
At pH 9.13, a substantial amount (50 %) of the less soluble free base would be present 
to cause a significant decrease in drug release. In this study, phenolphthalein was 
incorporated into matrices containing pH-modifiers. This pH indicator would turn 
pink at about pH 9. Cross-sections of matrices immersed for 1 h in 0.1 N hydrochloric 
acid did not show any pink coloration, indicating that the micro-environmental pH 
was less than 9. Hence, the inclusion of pH-modifiers did not increase micro-
environmental pH sufficiently to produce significant amounts (> 50 %) of free base. 
This strongly suggests that any retardation in drug release from matrices with sodium-
containing pH-modifiers was mainly due to the effects on the alginate polymer. 
 
Being water-soluble salts, the additives will also exert actions other than pH-
modification. The presence of such additives can lead to changes in polymer 
hydration (Siepe et al., 2006; Pillay and Fassihi, 1999) and cause channeling within 
the diffusion barrier. Despite possible channeling effects brought about by dissolution 
of pH-modifiers, slower drug release was observed. The lack of drug release 
retardation from matrices containing sodium chloride, a neutral salt, showed that 
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changes in drug release from matrices containing pH-modifiers were attributed mainly 
to their pH-modifying effects. This was further substantiated by comparing the 
performance of matrices containing sodium bicarbonate with those containing 
calcium carbonate at 20 % additive concentration. Even with an air-bubble barrier, 
matrices containing 20 % calcium carbonate did not reduce drug release as much as 
matrices containing 20 % sodium bicarbonate (45 % drug released for the former 
compared to 20 % for the latter at 2 h of dissolution). Even though both salts have 
similar pKa values (Table 24), the lower solubility of calcium carbonate compared to 
sodium bicarbonate could have limited its availability to modulate matrix micro-
environmental pH. Direct measurements of intragel pH of non-ionic matrices 
containing pH-modifiers immersed in pH 1.5 dissolution medium showed that sodium 
bicarbonate induced higher intragel pH compared to calcium carbonate (7.037 and 
5.674, respectively) (Pillay and Fassihi, 1999). These observations suggested that the 
main mechanism contributing to drug release retardation from matrices containing 
pH-modifiers was the increase in micro-environmental pH. In the case of sodium 
bicarbonate, the effervescence effect reinforced the function of the diffusion barrier.  
 
The mechanism of drug release from swelling polymeric matrices can be elucidated 
by fitting drug release data to the power law (Ritger and Peppas, 1987a, b). However, 
this equation has not been applied for analysis of drug release from matrix systems 
that show extensive crack formation. Earlier studies (Part 2, page 102) on non-
laminating alginate matrices showed that drug release at pH 1.2 was governed mainly 
by Fickian diffusion, as indicated by n values (diffusional exponent of the power law) 
close to 0.45. For comparative purposes, drug release data were curve-fitted to zero 
order or Higuchi equations up to 90 % drug release. Drug release at pH 1.2 and 6.8 
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followed pseudo zero order and Higuchi kinetics, respectively (Table 23), in contrast 
to previous findings. As explained earlier, linear release kinetics in the acidic phase 
can be attributed to increasing surface area exposed to dissolution media with time, 
brought about by matrix lamination. Linear kinetics at pH 1.2 was maintained in the 
presence of pH-modifiers. Although drug release followed Higuchi kinetics at pH 6.8, 
the actual mechanism of drug transport might not be Fickian diffusion since the 
Higuchi model is only applicable to non-swelling, non-eroding planar matrix systems 
(Higuchi, 1961 and 1963). Curve-fitting to the Higuchi model was carried out for 
comparative purposes only. Previous findings using Manucol SS/LL and Manucl LB 
alginate showed linear release at pH 6.8 (Table 14, page 85). The non-linear release at 
pH 6.8 observed in this study could be due to the presence of pH-modifiers in the 
alginate matrices. A reduction in matrix erosion due to textural stiffening in 
electrolyte-containing matrix formulations was proposed by Pillay and Fassihi (1999). 
Similar mechanism could have contributed to lower erosion rates in alginate matrices 
containing pH-modifiers. Greater retention of gel barrier due to lower extent of matrix 
erosion increased the drug diffusion path length, resulting in decreasing rates of drug 
release at pH 6.8. For control matrices, non-linear kinetics at pH 6.8 was mainly due 
to depleting drug content as 60 % of drug was released at pH 1.2. 
 
B2. Mechanistic study  
To test the hypothesis that pH-modifiers reduced the extent of matrix lamination by 
decreasing the extent of protonation of alginate within hydrating matrices, liquid 
penetration and image analysis studies were carried out on matrices with or without 
20 % pH-modifiers to examine the effects of pH-modification on matrix micro-
environmental pH and matrix morphology. 
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B2.1 Influence on matrix micro-environmental pH 
The micro-environmental pH within hydrating alginate matrices was visualized with 
the aid of a pH-indicator, bromophenol blue. As explained earlier, this indicator turns 
yellow when pH is below 3, corresponding closely to the pH below which more than 
50 % of sodium alginate is transformed to alginic acid. Hence, the yellow region 
within the matrix was composed mainly of alginic acid while the region that remained 
as sodium alginate appeared blue. Control matrices showed a high proportion of 
yellow region (Fig. 29), suggesting extensive conversion of sodium alginate to alginic 
acid at pH 1.2. The proportion of yellow region was significantly reduced from 70 % 
to below 50 % at 2 h of dissolution in acid with the addition of pH-modifiers (Fig. 
30), indicating reduced formation of alginic acid within these matrices. Conversely, 
the proportion of hydrated area remaining as sodium alginate increased in the 
presence of these additives. Thus, the inclusion of pH-modifiers effectively impeded 
the rapid conversion of sodium alginate to alginic acid by temporarily raising the 
micro-environmental pH beyond the pKa of alginate. Increased micro-environmental 
pH allowed the formation of viscous sodium alginate gel when sufficiently hydrated, 
which retarded the release of drug from matrices containing pH-modifiers.  
 
As the soluble additives leached out of the matrices, the micro-environmental pH 
within the outer layer adapted to the media pH, resulting in a gradual increase in the 
proportion of yellow region with time (Fig. 30). Upon dissolution media pH change 
from 1.2 to 6.8, the proportion of blue region increased rapidly with the re-conversion 
of alginic acid to sodium alginate. 
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Fig. 29. Cross-sectional images of hydrated matrices with or without 20 % pH-modifiers. The outermost layer is stained yellow, the 
inner layer is stained dark blue, while the dry core appeared whitish. The dry core of matrices containing 20 % tri-sodium 




































Fig. 30. The influence of 20 % pH-modifiers on the proportion of yellow (open 
symbols) and blue regions (closed symbols) within alginate matrices at pH 1.2. The 
proportion of colored area is expressed as a percentage of the entire matrix cross-
sectional area. Control (○, ●); sodium acetate (□, ■); tri-sodium phosphate (∆, ▲); 
sodium bicarbonate (◊, ♦).  
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B2.2 Influence on alginate matrix morphology during hydration in acidic phase 
The addition of pH-modifiers resulted in distinct changes in the morphology of 
alginate matrices during dissolution in the acidic phase (Fig. 29, 31). Control matrices 
showed extensive formation of laminates. Although cracks were formed on the axial 
surfaces, they were more dominant on the radial surface as explained earlier. The 
cracks extended towards the dry core as dissolution proceeded and gradually 
increased the surface area exposed to the dissolution medium.  This compromised the 
integrity of the alginic acid barrier and resulted in rapid drug release in the acidic 
phase.  
 
The incorporation of 20 % tri-sodium phosphate reduced the extent of matrix 
lamination (Fig. 29, 31). Crack propagation towards the core was reduced and was 
confined to the outer alginic acid layer (stained yellow). In contrast, the addition of 20 
% sodium acetate prevented the formation of laminates. Cracks formed mainly in the 
axial plane and extended towards the radial surface. Matrices containing 20 % sodium 
bicarbonate retained intact barriers throughout the acidic phase. The surface appeared 
rough and porous due to formation of air vesicles within the alginic acid layer.  
 
The absence of lamination in matrices containing sodium bicarbonate or sodium 
acetate could be due to retarded protonation of alginate during the early stages of 
hydration brought about by greater pH-elevating effects of these additives compared 
to tri-sodium phosphate (Table 24). In addition to transient increase of pH on the 
matrix surface, observations showed that effervescence from sodium bicarbonate-
containing matrices conferred further protection and allowed the surface layer to 
remain as viscous sodium alginate. The alginic acid layer formed was porous due to 
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                                                 Fig. 31(A) Axial view of hydrated alginate matrices with or without pH-modifiers 
 143
                                     
                                                    Fig. 31(B) Radial view of hydrated alginate matrices with or without pH-modifiers.
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entrapped air vesicles, allowing room for expansion within this layer to accommodate 
the swelling matrix. However, sodium acetate exacerbated the cracks on the axial 
surfaces of alginate matrices (Fig. 31). Measurements of hydrated layer thickness 
(Table 25) revealed that the extent of initial liquid penetration (y-intercept of hydrated 
layer thickness versus time plot) in the axial direction increased in the presence of 
sodium acetate and sodium bicarbonate (measurements in the latter could be elevated 
due to presence of air vesicles), giving rise to enhanced initial matrix swelling in the 
axial surface (Fig. 32). However, the rate of axial swelling for these matrices at pH 
1.2 was lower than that of control matrices (Fig. 32). The average rate of axial 
swelling was 1.27, 0.45 and 0.36 %/min, for matrices without pH-modifier, matrices 
containing 20 % sodium acetate and matrices containing 20 % sodium bicarbonate, 
respectively. The slower increase in axial dimension enabled the integrity of the radial 
barrier to be preserved. Greater swelling of the axial surfaces created greater tension 
within the axial alginic acid barrier, resulting in more prominent cracks.  
 
Table 25. Influence of 20 % pH-modifiers on the rate of increase in hydrated layer 
thickness in the radial and axial directions. The Y-intercept of hydrated layer 
thickness versus time plot represents the initial liquid penetration in the radial and 
axial directions.  
 
pH-modifiers Rate of increase in hydrated 
layer thickness (mm/min) 
Y-Intercept (mm) 
 Radial Axial Radial Axial 
     
Control 0.034 (0.001) 0.026 (0.001) 0.575 (0.085) 0.707 (0.102) 
Tri-sodium 
phosphate 
0.033 (0.001) 0.025 (0.002) 0.711 (0.062) 0.794 (0.107) 
Sodium acetate 0.031 (0.001) 0.025 (0.002) 1.249 (0.072)a 1.621 (0.107)a 
Sodium bicarbonate 0.026 (0.002)a 0.019 (0.002)a 1.274 (0.123)a 1.954 (0.163)a 
 
























Fig. 32. Dimensional changes of alginate matrices in the radial (open symbols) and 
axial directions (closed symbols) at pH 1.2 in the presence of 20 % pH-modifiers. 
Control (○, ●); sodium acetate (□, ■); tri-sodium phosphate (∆, ▲); sodium 




In general, the inclusion of pH-modifiers reduced or removed the propensity of 
Manugel DMB matrices to laminate during dissolution in the acidic phase. Close 
examination of the images showed that cracks were only found within the alginic acid 
layer (stained yellow) (Fig. 33). Apparently, the rigid, non-viscous outer layer of 
alginic acid was forced to crack with gradual matrix expansion. Further matrix 
swelling resulted in crack propagation towards the core, which was halted at the 
color-change interface (Fig. 33). This suggests that the extent of crack formation can 
be minimized by reducing the formation of alginic acid. Previously, it was mentioned 
that sodium alginate matrices did not crack in non-acidic environment, but formed 
intact matrices with smooth viscous barrier. In contrast to alginic acid, the more 
soluble sodium alginate is better able to accommodate swelling pressure as it is 
transformed to a viscous phase with imbibed liquid. Hence, increased proportion of 
sodium alginate within the hydrated area in matrices containing pH-modifiers could 
have prevented further loss of barrier integrity.  
 
The overlapping profiles of % yellow area in the acidic phase for matrices containing 
tri-sodium phosphate or sodium acetate (Fig. 30) indicated similar extent of alginic 
acid formation despite different crack patterns shown by these matrices. This could 
have resulted in barriers with similar diffusivities which gave rise to similar drug 














Fig. 33. Cross-sectional images showing cracked regions (indicated by arrows) within 
hydrated alginate matrices for matrices without pH-modifiers (A, B, C) and matrices 











B2.3 Effect on liquid uptake and matrix erosion 
The inclusion of pH-modifiers into hydrophilic matrices led to changes in polymer 
hydration (Siepe et al., 2006; Pillay and Fassihi, 1999). Hence, the influence of these 
additives on liquid uptake and erosion of alginate matrices was determined.  
 
The rate of liquid uptake in the acidic phase decreased with the addition of pH-
modifiers (Table 26). However, initial liquid uptake (Y-intercept of % liquid uptake 
versus time plot) was higher for matrices containing 20 % sodium bicarbonate. 
Similarly, the rate of increase in hydrated layer thickness in both axial and radial 
directions decreased while the initial liquid penetration (Y-intercept of hydrated layer 
thickness versus time plot) increased in the presence of some these additives (Table 
25). The presence of pH-modifiers promoted initial wetting of alginate matrices, 
contributing to faster barrier formation, which slowed down subsequent liquid uptake. 
More importantly, reduced crack formation in these matrices decreased surface area 
for liquid uptake. Likewise, matrices containing pH-modifiers showed lower rates of 
liquid uptake at pH 6.8 compared to control matrices (Table 26). Apparently, the 
presence of soluble additives at 20 % concentration did not compromise barrier 
integrity by causing significant channeling. On the contrary, the dissolution of pH-
modifiers resulted in pH-modulation of the alginate matrix micro-environment, which 







Table 26. Influence of 20 % pH-modifiers on the rate of liquid uptake at pH 1.2 and 
pH 6.8. The Y-intercept of % liquid uptake versus time plot at pH 1.2 represents the 
initial liquid uptake.  
 
pH-modifiers Rate of liquid uptake 
 pH 1.2 (%/min) pH 6.8 (%/min0.5) 
Y-intercept  
at pH 1.2 (%) 
    
Control 1.26 (0.11) 138.50 (11.94) 77.28   (6.97) 
Tri-sodium phosphate 1.08 (0.05) 97.13   (6.11)a 60.10   (3.22) 
Sodium acetate 0.97 (0.03)a 87.53   (2.74)a 73.68   (2.40) 
Sodium bicarbonate 0.87 (0.13)a 76.71   (2.52)a 120.30 (8.98)a 
 
a Significantly different compared to control (P < 0.05)  
 
 
The rate of matrix erosion in the acidic phase was not affected by the presence of pH-
modifiers (Table 27). At pH 6.8, matrices containing pH-modifiers showed lower 
erosion rates (Table 27), mainly because of reduced surface area for hydration 
brought about by a reduction in crack formation, which decreased the rate at which 
the ‘disentanglement concentration’ was reached. The ‘disentanglement 
concentration’ is the critical polymer concentration below which the polymer chains 
disentangle and detach from a gelled matrix (Kavanagh and Corrigan, 2004). This 
occurs as the gel layer becomes more dilute with time. Moreover, Pillay and Fassihi 
(1999) reported that electrolyte-containing matrix formulations showed a two-fold 
reduction in matrix erosion through drug-electrolyte interaction and related 
mechanisms of textural stiffening. Similar mechanism could have contributed to 
lower erosion rates in additive-containing alginate matrices. Although matrix erosion 
rate at pH 6.8 was reduced in the presence of pH-modifiers, drug release rate at this 
pH was only significantly reduced for matrices containing 20 % sodium bicarbonate 
(Table 27). In addition to erosion of gel barrier, matrix morphology at pH 1.2 could 
have affected subsequent drug release from alginate matrices at pH 6.8.  
 150
Table 27. Influence of 20 % pH-modifiers on alginate matrix erosion rates at pH 1.2 
and pH 6.8.  
 
pH-modifiers Rate of matrix erosion 
 pH 1.2 (%/min) pH 6.8 (%/min0.5)
Drug release rate at 
pH 6.8 (%/min0.5) 
    
Control 0.12 (0.01) 9.08 (0.32) 4.51 (0.41) 
Tri-sodium phosphate 0.13 (0.01) 5.41 (0.71)a 4.13 (0.16) 
Sodium acetate 0.15 (0.01) 3.98 (0.17)a 3.71 (0.12) 
Sodium bicarbonate 0.11 (0.01) 3.53 (0.13)a 3.39 (0.07)a 
 
a Significantly different compared to control (P < 0.05) 
 
By enhancing initial matrix hydration and reducing matrix erosion rates, drug release-
retarding property of alginate matrices was probably enhanced. Nevertheless, the 
contribution of these effects was secondary to the pH-modifying effects since the 
integrity of the diffusion barrier in the initial acidic phase was highly-dependent on 















The influence of alginate physicochemical properties on drug release and hydration 
behavior of alginate matrix tablets was investigated under simulated gastrointestinal 
pH conditions using a variety of alginate grades. The role of the size of the primary 
particles of alginate was reflected in the initial stages of diffusion barrier 
development, particularly at low alginate content where the relative abundance of 
surface polymer particles was dependent on the alginate particle size. The use of 
smaller alginate particles reduced the extent of burst release, indicating faster 
development of the diffusion barrier while the use of larger particles produced 
disintegrating matrices. The effect of particle size was observed up to a threshold 
level of about 80-100 µm at 10 % alginate content. The influence of alginate particle 
size diminished at higher alginate content as the proximity of constituent polymer 
particles was enhanced. The rate of alginate polymer hydration also governed the rate 
of barrier formation. At pH 1.2, higher viscosity alginate reduced the rate of polymer 
hydration and resulted in greater burst in drug release. Slower polymer hydration of 
higher viscosity alginate was reflected by lower initial values of liquid uptake, axial 
swelling and % hydrated area. In contrast, higher viscosity alginate formed more 
viscous gel barriers with reduced erodibility at pH 6.8. The MG ratio of alginate also 
exerted contrasting effects at pH 1.2 and pH 6.8. Matrices of high-G alginate appeared 
to crack more extensively at acidic pH while forming stiffer gels with reduced 
erodibility at pH 6.8. Extensive crack formation enhanced the liquid penetration into 
and drug release out of the matrix. These findings suggest that drug release from 
alginate matrices can be modulated using alginates of suitable particle size, viscosity 
and MG ratio. Anisotropic matrix swelling and liquid penetration suggests non-
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uniform drug release rates from different parts of the matrix. This could be important 
in matrix design and modeling studies.  
 
Two formulation strategies were proposed to minimize crack formation observed in 
alginate matrices. These involved the use of cross-linkers or pH-modifiers. The 
influence of the type and amount of cross-linker, internal/external cross-linking as 
well as the pH of the dissolution medium were examined. In general, the 
incorporation of calcium salts into sodium alginate matrix tablets did not significantly 
promote drug release retardation. Competing mechanisms such as channeling effect of 
soluble calcium salts, enhanced matrix lamination and matrix erosion, as well as 
competition with hydrogen ions at acidic pH interfered with cross-linking and even 
resulted in faster drug release. Significant drug release retardation was only achieved 
when in situ cross-linking was carried out in water containing calcium ions at 
relatively low concentrations. At high cross-linker concentrations, matrix 
disintegration occurred resulting in dose-dumping. Gravimetric and image analysis 
studies showed that rapid initial liquid uptake was critical in reducing the extent of 
initial drug released by promoting rapid polymer swelling to form an effective drug 
diffusion barrier. This process was impeded by high cross-linker concentration, 
resulting in faster initial drug release. Matrices pre-coated with calcium alginate 
significantly reduced the release of a highly-water soluble drug at pH 1.2, mainly by 
preserving matrix structure. This strategy can be employed to impede crack 
development in alginate matrices in acidic media. Zero order release as well as 
delayed burst release could be achieved by employing appropriate grade of alginate 
and cross-linking conditions 
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Modification of micro-environmental pH minimized crack formation by retarding the 
conversion of sodium alginate to alginic acid, leading to greater drug release 
retardation at pH 1.2. Generation of a physical air barrier by sodium bicarbonate 
further decreased the rate of drug release. The effect of the soluble additives on matrix 
hydration and erosion was secondary compared to their pH-modifying effects. This 
approach can also be used to overcome alginate matrix lamination during hydration in 
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Appendix 1. Effect of cryo-treatment on alginate matrix dimension. Percentage radial 
(○, ●) and axial (□, ■) swelling measured before (open symbols) and after (closed 



























































Appendix 2. Boxplots for (A) drug release rate and (B) Y-intercept values for high-M 




Appendix 3. Multiple comparison using Bonferroni test on (A) drug release rate and 
(B) Y-axis intercept from matrices containing alginate sieved fractions at 5 and 10 % 






5 % 10 %  
180-250 125-180 90-125 <90 180-250 125-180 90-125
180-250 - 0.005a 0.000a 0.000a    
125-180  - 0.021a 0.009a    
90-125   - 1.000    
 
5 % 
<90    -    
180-250     - 0.029a 0.155 
125-180      - 0.709 
 
10 % 
90-125       - 
 
(B) 
5 % 10 %  
180-250 125-180 90-125 <90 180-250 125-180 90-125
180-250 - 1.000 1.000 0.018a    
125-180  - 1.000 0.007a    
90-125   - 0.005a    
 
5 % 
<90    -    
180-250     - 0.020a 0.000a 
125-180      - 0.004a 
 
10 % 
90-125       - 
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          Appendix 4. Multiple comparison using Bonferroni test on Y-intercept values for matrices containing milled alginate fractions at  
          5, 10, 30 and 50 % alginate content. Significance is denoted by P < 0.05 a.  
 
5 % 10% 30 % 50 %   
  88 60 44 41 88 60 44 41 88 60 44 41 88 60 44 41 
88 - 0.257 0.002a 0.002a                         
60   - 0.403 1.000                         





 41       -                         
88         - 0.39 0.014a 0.003a                 
60           - 1.000 0.562                 





 41               -                 
88                 - 1.000 0.001a 0.059         
60                   - 0.005a 0.593         





 41                       -         
88                         - 1.000 1.000 1.000
60                           - 0.273 0.562
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